EP1453817A1 - Thiazole derivatives with fungicidal activity - Google Patents

Thiazole derivatives with fungicidal activity

Info

Publication number
EP1453817A1
EP1453817A1 EP02795153A EP02795153A EP1453817A1 EP 1453817 A1 EP1453817 A1 EP 1453817A1 EP 02795153 A EP02795153 A EP 02795153A EP 02795153 A EP02795153 A EP 02795153A EP 1453817 A1 EP1453817 A1 EP 1453817A1
Authority
EP
European Patent Office
Prior art keywords
group
optionally substituted
branched
linear
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP02795153A
Other languages
German (de)
French (fr)
Other versions
EP1453817B1 (en
Inventor
Marilena Gusmeroli
Alessandro Ciapessoni
Franco Bettarini
Samuele Osti
Luigi Mirenna
Giovanni Camaggi
Alexia Elmini
Ramona Gironda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Isagro Ricerca SRL
Original Assignee
Isagro Ricerca SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITMI20012640 external-priority patent/ITMI20012640A1/en
Priority claimed from IT2002MI000753A external-priority patent/ITMI20020753A1/en
Application filed by Isagro Ricerca SRL filed Critical Isagro Ricerca SRL
Publication of EP1453817A1 publication Critical patent/EP1453817A1/en
Application granted granted Critical
Publication of EP1453817B1 publication Critical patent/EP1453817B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/74Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,3
    • A01N43/781,3-Thiazoles; Hydrogenated 1,3-thiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Definitions

  • the present invention relates to new thiazole derivatives.
  • the present invention relates to new thiazole derivatives having high fungicidal activity, the process for their preparation, and their use for the control of phytopathogenic fungi, in particular in the agrarian field.
  • Strobilurines are fungal metabolites chemically characterized by the presence of the group 1- r ⁇ ethoxycarbonyl-2-methoxyethen-l-yl ("Pesticide Science", 1991, page 499) .
  • the Applicant has now found new analogous products of strobilurines, chemically characterized by the presence of a 4-thiazole group, having a good stability and surprisingly high fungicidal activity with respect to phytopathogenic fungi, together with a good selectivity towards the vegetables to which they are applied.
  • the object of the present invention therefore relates to compounds having general formula (I) :
  • Ri represents a hydrogen atom; a linear or branched C ⁇ -C 6 alkyl or haloalkyl group, optionally substituted; a C 2 -C 6 alkenyl or haloalkenyl group, optionally substituted; a C 2 -
  • R 2 represents a hydrogen atom; a halogen atom selected from chlorine, fluorine, bromine or iodine; a linear or branched C ⁇ -C 6 alkyl or haloalkyl group, optionally substituted; a linear or branched C 2 -C 6 alkenyl or haloalkenyl group, optionally substituted; a linear or branched C 2 -C 3 alkynyl or haloalkynyl group, optionally substituted; a C 3 -C 6 cycloalkyl group, optionally substituted; a linear or branched Ci- C 6 alkoxy or haloal
  • R 3 and R 4 independently represent a linear or branched C 1 -C 4 alkyl group
  • R 5 represents a halogen atom, optionally selected from fluorine, chlorine, bromine or iodine; a linear or branched Ci-C ⁇ haloalkyl group, optionally substituted; a linear or branched C ⁇ -C 6 alkoxy group, optionally substituted; a linear or branched C ⁇ -C 6 haloalkoxy group, optionally substituted; a linear or branched C ⁇ -C 6 alkylthio group, optionally substituted; a linear or branched Ci- C 6 haloalkylthio group, optionally substituted; a C 3 -C 6 cycloalkyl group optionally substituted; a linear or branched C 2 -C 8 alkoxycarbonyl group; a cyano group; when R x represents a linear or branched C ⁇ -C 6 haloalkyl group, substituted by at least two halogen atoms, the same
  • R 5 also represents a linear or branched Ci-Ce alkyl group, optionally substituted;
  • Y represents an oxygen atom; an NH group;
  • Z represents a nitrogen atom or a CH group;
  • n is a number ranging from 0 to 4.
  • Ri represents a hydrogen atom; a linear or branched C ⁇ -C 3 alkyl or haloalkyl group, optionally substituted; a C 2 -C 6 alkenyl or haloalkenyl group, optionally substituted; a C 2 - C 6 alkynyl or haloalkynyl group, optionally substituted; a C 3 -C 6 cycloalkyl group, optionally substituted; an aryl group, optionally substituted; a heteroaryl group, optionally substituted; a heterocyclic group, optionally substituted; a halogen atom;
  • R 2 represents a hydrogen atom; a halogen atom selected from chlorine, fluorine, bromine or iodine; a linear or branched C ⁇ -C 6 alkyl or haloalkyl group, optionally substituted; a linear or branched C 2 -C 6 alkenyl or haloalkenyl group, obtionally substituted; a linear or branched C 2 ⁇ C 6 alkynyl or haloalkynyl group, optionally substituted; a C 3 -C 6 cycloalkyl group, optionally substituted; a linear or branched C ⁇ C 6 alkoxy or haloalkoxy group, optionally substituted; a linear or branched C ⁇ -C 6 alkylthio or haloalkylthio group, optionally substituted; a C 3 -C 6 cycloalkoxy group, optionally substituted; a cyano group; a linear or branched C 2 -C 8
  • R 5 represents a halogen atom, optionally selected from fluorine, chlorine, bromine or iodine; a linear or branched C ⁇ -C 6 haloalkyl group, optionally substituted; a linear or branched C ⁇ -C 6 alkoxy group, optionally substituted; a linear or branched C ⁇ -C 6 haloalkoxy group, optionally substituted; a linear or branched C ⁇ -C 6 alkylthio group, optionally substituted; a linear or branched Ci- C 6 haloalkylthio group, optionally substituted; a C 3 -C 6 cycloalkyl group, optionally substituted; a linear or branched C 2 -C 8 alkoxycarbonyl group; a cyano group; when R x represents a linear or branched C ⁇ -C 6 haloalkyl group substituted by at least two halogen atoms, the
  • R 5 also represents a linear or branched C ⁇ -C 6 alkyl group, optionally substituted;
  • Y represents an oxygen atom; an NH group;
  • Z represents a nitrogen atom or a CH group;
  • n is a number ranging from 0 to 4, he control of phytopathogenic fungi.
  • the use of the compounds having formula (I) for the control of phytopathogenic fungi is curative and/or preventive.
  • the Ri group is preferably selected from a linear or branched Ci- C 6 alkyl or haloalkyl group, optionally substituted; a C 3 ⁇ C 6 cycloalkyl group, optionally substituted; an aryl group, optionally substituted; a heteroaryl group, optionally substituted.
  • the R 2 group is preferably selected from a hydrogen atom; a halogen atom; a linear or branched Ci-Ce alkyl or haloalkyl group, optionally substituted; a C 3 -C 6 cycloalkyl group, optionally substituted; a linear or branched C 2 -C 8 alkoxycarbonyl group, optionally substituted.
  • R 3 and R 4 are preferably equal to a methyl group, whereas R 5 is preferably selected from a halogen atom, a C ⁇ -C 6 haloalkyl group or, when Ri represents a Ci-C ⁇ haloalkyl group, R 5 preferably represents a linear or branched C ⁇ -C 6 alkyl group, optionally substituted.
  • n is preferably equal to 0 or 1
  • Z is preferably equal to CH and Y is preferably an oxygen atom.
  • a C ⁇ -C 6 alkyl group refers to a linear or branched C ⁇ -C 6 alkyl group.
  • Ci-C ⁇ haloalkyl group refers to a linear or branched alkyl group substituted by one or more halogen atoms, the same or different.
  • a polyhaloalkyl group refers to a haloalkyl group substituted by at least two halogen atoms, the same or different.
  • Examples of this group are: fluoromethyl, chlorodifluoro ethyl, difluoromethyl, trifluoro- methyl, trichloro ethyl, 2, 2, 2-trifluoroethyl, 2,2,2- trichloroethyl, 1, 1, 2, 2, 2-pentafluoroethyl, 1,1,2,2- tetrafluoroethyl, 1, 2, 2, 2-tetrafluoroethyl, 2,2,3,3- tetrafluoropropyl, 2,2,3,3, 3-pentafluoropropyl .
  • a C 2 -C 6 alkenyl group refers to a linear or branched C 2 -C 6 alkenyl group.
  • Examples of this group are: ethenyl, propenyl, butenyl .
  • a C 2 -C 6 haloalkenyl group refers to a linear or branched C 2 -C alkenyl group, substituted by one or more halogen atoms, the same or different.
  • Examples of this group are: 2, 2-dichloropropenyl, 1,2,2-trichloropropenyl.
  • Examples of C 2 -C 6 alkynyl groups are: ethynyl, propargyl .
  • a C 2 -C 6 haloalkynyl group refers to a C 2 -C 6 alkynyl group substituted by one or more halogen atoms, the same or different.
  • C 2 -C 6 haloalkynyl group 3- chloropropynyl .
  • a C 3 -C 6 cycloalkyl group refers to a cycloalkyl group whose ring consists of 3-6 carbon atoms, optionally substituted by one or more substituents, the same or different.
  • Examples of this group are: cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl.
  • a C ⁇ C 6 alkoxy group refers to a C ⁇ -C 6 alkoxy group, wherein the aliphatic portion is a C ⁇ -C 6 alkyl group, as defined above.
  • Examples of this group are: methoxy, ethoxy.
  • a C ⁇ -C 6 haloalkoxy group refers to a C ⁇ -C 6 haloalkoxy group, wherein the aliphatic portion is a C ⁇ -C 6 haloalkyl group, as defined above.
  • a C ⁇ -C 6 alkylthio group refers to a C ⁇ -C 3 alkylthio group, wherein the aliphatic portion is a C ⁇ -C 6 alkyl group, as defined above.
  • Examples of this group are: methylthio, ethylthio .
  • Ci-C ⁇ haloalkylthio group refers to a C ⁇ -C 6 haloalkylthio group wherein the aliphatic portion is a Ci-C ⁇ haloalkyl group, as defined above.
  • Examples of this group are: trifluoromethylthio, 1, 1,2, 2-tetrafluoroethylthio.
  • a C 3 -C 6 cycloalkoxy group refers to a C 3 -C 6 cycloalkoxy group wherein the aliphatic portion is a C 3 -C 6 cycloalkyl group, as defined above.
  • Examples of this group are: cyclopentoxy, cyclohexyloxy.
  • a C 2 -C 8 alkoxycarbonyl group refers to an alkoxycarbonyl group wherein the aliphatic portion is a Ci-C alkyl group, as defined above.
  • Examples of this group are: methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl .
  • a C 2 -C 8 alkylaminocarbonyl or C 3 -C ⁇ 5 dialkylaminocarbonyl group refers to an alkylaminocarbonyl or dialkylaminocarbonyl group wherein the aliphatic portion is one or two C ⁇ -C 7 alkyl groups respectively, as defined above. Examples of this group are: N- methylaminocarbonyl, N,N-dimethylaminocarbonyl, N- isopropylaminocarbonyl, N-ethyl-N-methylaminocarbo- nyl.
  • a C 2 -C 8 alkylcarbonyl group refers to an alkylcarbonyl group wherein the aliphatic portion is a C 1 -C7 alkyl group, as defined above.
  • aryl group refers to an aromatic carbocyclic group optionally substituted by one or more groups the same or different.
  • Examples of this group are: phenyl, naphthyl.
  • a heteroaryl group refers to an aromatic heterocyclic penta- or hexa-atomic group, also benzocondensed or heterobicyclic, containing from 1 to 4 hetero-atoms selected from nitrogen, oxygen, sulfur, optionally substituted by one or more groups, the same or different.
  • heteroaryl groups are: pyridine, pyrimidine, pyridazine, pyrazine, triazine, tetrazine, quinoline, quinoxaline, quinazoline, furan, thiophene, pyrrole, oxazole, thiazole, isoxazole, isothiazole, oxadiazole, thiadiazole, pyrazole, imidazole, triazole, tetrazole, indole, benzofurane, benzothiophene, benzoxazole, benzothiazole, benzoxadiazole, benzothiadiazole, benzopyrazole, benzimidazole, benzotriazole, triazolopyridine, triazolopyrimidine, thiazolotriazo- le.
  • a heterocyclic group refers to a saturated or unsaturated ring with from three to twelve units, • containing at least one hetero-atom selected from nitrogen, oxygen, sulfur, optionally condensed with another aromatic or non-aromatic ring.
  • heterocyclic rings are: pyrrolidine, piperidine, dihydropiperidine, dihydropyridine, piperazine, morpholine, thiazine, indoline.
  • the term optionally or possibly substituted refers to a group which can have one or more substituents, the same or different, preferably selected from the following groups: halogen atoms possibly selected from chlorine, fluorine, bromine, iodine; C ⁇ -C 6 alkyl, alkoxy, alkylthio, in turn optionally substituted by halogen atoms; alkoxycarbonyl or alkylaminocarbonyl optionally halogenated; aminocarbonyl; C 2 -C a dialkylaminocarbonyl optionally halogenated; C 2 -C 8 alkylcarbonyl; C 2 -C 8 alkylcarbonyloxy; cyano; nitro; formyl; hydroxy; amino; carboxy.
  • the compounds having formula (I) have high fungicidal activity.
  • a further object of the present invention relates to the processes for the preparation of the compounds having general formula (I) .
  • the compounds having general formula (I) can be obtained by the condensation of a compound having general formula (II) with a thiazolyl derivative having general formula (III) , according to reaction scheme A: Scheme A
  • L represents a leaving group such as a chlorine atom, a bromine atom, an RS0 3 ⁇ group wherein R represents a C ⁇ -C 6 alkyl or haloalkyl or a phenyl optionally substituted.
  • the reaction can be conveniently carried out in an inert organic solvent, at a temperature ranging from 0°C to the boiling point of the reaction mixture, optionally in the presence of an inorganic or organic base.
  • Preferred solvents for the reaction are: alcohols (methanol, ethanol, propanol, methoxyethanol etc.); ethers (ethyl ether, isopropyl ether, tetrahydrofuran, dioxane, dimethoxyethane, etc.); esters (ethyl acetate, etc.); ketones (acetone, methylethylketone etc.); chlorinated hydrocarbons (methylene chloride, dichloroethane, chloroform, carbon tetrachloride, etc.); aromatic hydrocarbons
  • Preferred inorganic bases are: hydrides, hydroxides, carbonates of alkaline or earth-alkaline metals (sodium, potassium, calcium, etc.).
  • Preferred organic bases are: pyridine, dimethylaminopyridine, aliphatic amines, (diethyl- amine, triethylamine, etc.), cyclic amines (morpholine, piperidine, diazabicycloundecene, etc.); alcoholates of alkaline metals (potassium t-butylato, etc. ) .
  • the compounds having general formula (I), wherein Z is N and Y is NH can be alternatively obtained by the reaction of the corresponding compound having formula (I) wherein Z is N and Y is 0 with a suitable a ine having the formula R 4 NH 2 wherein R 4 has the meanings defined above.
  • the reaction can be conveniently carried out in an inert organic solvent, at a temperature ranging from 0°C to the boiling point of the reaction mixture .
  • Preferred solvents for the reaction are: alcohols (methanol, ethanol, propanol, methoxyethanol, etc.); ethers (ethyl ether, isopropyl ether, tetrahydrofuran, dioxane, dimethoxyethane, etc.); ketones (acetone methylethylketone etc.); chlorinated hydrocarbons (methylene chloride, dichloroethane, chloroform, carbon tetrachloride etc.); aromatic hydrocarbons (benzene, toluene, xylene, etc.); aliphatic hydrocarbons (hexane, heptane cyclohexane, etc.); dipolar aprotic solvents (N,N- dimethylformamide, dimethylsulfoxide, sulfolane, etc.); or mixtures
  • isomers E of the compounds having formula (I) are preferred, and consequently the use of isomers E of the compounds having formula (I), is also preferred.
  • the intermediates having general formula (II) are known compounds .
  • the thiazoles having general formula (III) when not known as such, can be prepared by means of the methods known in literature, according to what is described, for example, in: Journal of Medicinal Chemistry 1991, vol.34, pages 2158-2165.
  • the thiazoles having general formula (III) wherein Ri has the meaning of a linear or branched Cx-C ⁇ polyhaloalkyl group are new compounds .
  • a further object of the present invention therefore relates to compounds having general formula (III') :
  • Ri' represents a linear or branched C ⁇ -C 6 polyhaloalkyl group and R 2 ' has the same meaning as R 2 and their use as intermediates for the preparation of compounds useful both in the agrochemical and pharmaceutical field.
  • a C ⁇ -C 6 polyhaloalkyl group refers to a linear or branched C ⁇ -C 6 alkyl group substituted by at least two halogen atoms, the same or different.
  • the group Ri' is selected from trifluoromethyl, difluoromethyl, chlorodifluoro- methyl, 2, 2, 2-trifluoroethyl, 2, 2, 3, 3-tetrafluoropropyl, 2,2, 3,3, 3-pentafluoropropyl, 1,1,2,2,2- pentafluoroethyl, 1, 2, 2, 2-tetrafluoroethyl, 1,1,2,2- tetrafluoroethyl .
  • the group R 2 ' is preferably selected from a hydrogen atom, a halogen atom, a linear or branched C ⁇ -C 6 alkyl or haloalkyl group, optionally substituted, a C 3 -C 6 cycloalkyl group, optionally substituted; an aryl group, optionally substituted; a heteroaryl group, optionally substituted; a cyano group; a linear or branched C 2 -C 8 alkoxycarbonyl group, optionally substituted.
  • the compounds having formula (III' ) can also exist in a tautomeric ketonic form (IV), and also in mixtures between the two forms (III') e (IV) .
  • a further object of the present invention relates to the processes for the preparation of the compounds having general formula (III').
  • Ri' and R 2 ' have the meanings defined above
  • X represents a leaving group such as a chlorine atom, a bromine atom, a RS0 ⁇ group
  • W represents an OR group, wherein R has the meaning of a linear or branched C ⁇ -C 6 alkyl or haloalkyl or phenyl, optionally substituted; or a halogen atom; or an H2 group.
  • the reaction can be conveniently carried out in an inert organic solvent, at a temperature ranging from -70°C to the boiling point of the reaction mixture, optionally in the presence of an inorganic or organic base.
  • Preferred solvents for the reaction are: aromatic hydrocarbons (benzene, toluene, xylene, etc.); aliphatic hydrocarbons (hexane, heptane, cyclohexane, etc.); alcohols (methanol, ethanol, etc.); ethers (ethyl ether, isopropyl ether, tetrahydrofuran, dioxane, dimethoxyethane, etc.); esters (ethyl acetate, etc.); ketones (acetone, methylethylketone, etc.); chlorinated hydrocarbons (methylene chloride, dichloroethane, chloroform, carbon tetrachloride, etc.); dipolar aprotic solvents (N,N-dimethylformamide, dimethylsulfoxide, sulfolane, etc. ) .
  • Preferred inorganic bases are: hydrides, hydroxides, carbonates of alkaline and earth-alka
  • Preferred organic bases are: pyridine, dimethylaminopyridine, aliphatic amines, (diethylamine, triethylamine, etc.), cyclic amines (morpholine, piperidine, diazabicycloundecene, etc.); alcoholates of alkaline metals (potassium t-butylate, etc. ) .
  • the thioamides having general formula (V) when they are not known as such, can be prepared by means of the methods known in literature, according to what is described, for example, in : Houben-Weil Band E5 / Opera 1 (pages 1218-1277) .
  • the intermediates having general formula (VI) are compounds known in literature, for example, in: Journal American Chemical Society (1944), vol.66, page 2074; Synthesis (1969), page 39.
  • the compounds having general formula (III') can be obtained by condensation between a nitrile having formula (VII) and a carboxylic derivative having formula (VIII) according to reaction scheme C:
  • T represents an OH group or an OR group wherein R has the meaning of a linear or branched d.-
  • the reaction can be conveniently carried out in the presence of or in the absence of an inert organic solvent, at a temperature ranging from ⁇ 70°C to the boiling point of the reaction mixture, optionally in the presence of an inorganic or organic base or alternatively in the presence of an inorganic or organic acid.
  • Preferred solvents for the reaction are: aromatic hydrocarbons (benzene, toluene, xylene, etc.); aliphatic hydrocarbons (hexane, heptane, cyclohexane, etc.); alcohols (methanol, ethanol, ecc.) ; ethers (ethyl ether, isopropyl ether, tetrahydrofuran, dioxane, dimethoxyethane, etc.); esters (ethyl acetate, etc.); ketones (acetone, methylethylketone, etc.); chlorinated hydrocarbons (methylene chloride, dichloroethane, chloroform, carbon tetrachloride, etc.); dipolar aprotic solvents (N,N-dimethylformamide, dimethylsulfoxide, sulfolane, etc. ) .
  • Preferred inorganic bases are: hydroxides, carbonates of alkaline or earth-al
  • Preferred organic bases are: pyridine, dimethylaminopyridine, aliphatic amines, (diethyl- amine, triethylamine, etc.), cyclic amines
  • Preferred inorganic acids are: hydrochloric acid, sulfuric acid, etc.
  • Preferred organic acids are: acetic acid, citric acid, etc.
  • the nitriles having general formula (VII) and the carboxylic derivatives having general formula (VIII) when they are not known as such, can be prepared by means of the methods known in literature, for example, according to what is described in Journal American Chemical Society (1943), vol.65, page 1459.
  • the compounds having general formula (I) have a particularly high fungicidal activity against phytopathogenic fungi which attack vines, sugar beet, cereals, vegetables, rice, Cucurbitaceae, fruit trees.
  • phytopathogenic fungi which can be effectively fought with the compounds having general formula (I) are:
  • the compounds having general formula (I) are capable of exerting a fungicidal action of both a curative and preventive nature and have a low or non- existing phytotoxicity.
  • An object of the present invention therefore also relates to the use of the compounds having general formula (I) as insecticides and/or acaricides.
  • a further object of the present invention consequently relates to a method for the control of phytopathogenic fungi in agricultural crops by the application of the compounds having general formula
  • the quantity of compound to be applied to obtain the desired effect can vary in relation to various factors such as, for example, the compound used, the crop to be preserved, the type of pathogen, the degree of infection, the climatic conditions, the method of application, the formulation adopted.
  • compositions or compounds having formula (I) can be effected on any part of the plant, for example on the leaves, stems, branches and roots, or on the seeds themselves before sowing, or on the ground in which the plant grows .
  • compositions can be used in the form of dry powders, wettable powders, emulsifiable concentrates, micro-emulsions, pastes, granulates, solutions, suspensions, etc.: the choice of the type of composition will depend on the specific use.
  • compositions are prepared in the known way, for example by diluting or dissolving the active substance with a solvent medium and/or a solid diluent, optionally in the presence of surface-active agents .
  • Solid diluents, or carriers which can be used are, for example: silica, kaolin, bentonite, talc, fossil flour, dolomite, calcium carbonate, magnesia, chalk, clays, synthetic silicates, attapulgite, seppiolite.
  • Liquid diluents which can be used are, for example, in addition to water, aromatic organic solvents (xylols or alkyl benzene mixtures, chlorobenzene, etc.), paraffins (oil fractions), alcohols (methanol, propanol, butanol, octanol, glycerine, etc.), esters (ethyl acetate, isobutyl acetate etc.), ketones (cyclohexanone, acetone, acetophenone, isophorone, ethylamylketone, etc.), amides (N,N-dimethylformamide, N-methylpyrrolidone, etc. ) .
  • aromatic organic solvents xylols or alkyl benzene mixtures, chlorobenzene, etc.
  • paraffins oil fractions
  • alcohols methanol, propanol, butanol, octanol, gly
  • compositions can also contain special additives for particular purposes, for example adhesion agents such as arabic rubber, polyvinyl alcohol , polyvinylpyrrolidone, etc..
  • compositions compatible with the compounds having general formula (I), such as for example other fungicides, phytoregulators, antibiotics, herbicides, insecticides, fertilizers.
  • fungicides which can be included in the compositions of the invention are: AC-382042, acibenzolar, ampropylphos, anilazine, azaconazole, azoxystrobin, benalaxyl (in its racemic form or as an optically active R isomer) , benclothiaz, beno yl, bitertanol, blasticidin-S, bromuconazole, bupirimate, buthiobate, captafol, captan, carbendazim, carboxin, carpropamid, chinomethionat, chloroneb, chlorothalonil, chlozolinate, cyazofamid, cymoxanil, cyproconazole, cyprodinil, debacarb, dichlofluanid, dichlone, dichlobutrazol, dichlomezine, dichloran, dicyclomet, diethofencarb, diphen
  • fungicidal compounds are commercial compounds or compounds about to be commercialized. Their description can be easily found in technical literature, for example in "The pesticide manual", 2000, XII edition, British Crop Protection Council Ed.
  • Dipeptide with a fungicidal activity refers to one of the compounds among those claimed in patent application EP-A-1028125.
  • concentration of active principle in the above compositions can vary within a wide range depending on the active compound, the applications for which they are destined, the environmental conditions and type of formulation adopted.
  • the concentration of active principle generally ranges from 1% to 90%, preferably from 5 to 50%.
  • reaction mixture is diluted with water (200 ml) and extracted with ethyl acetate (100 ml x 2 times) .
  • the mixture is diluted with water (20 ml) and extracted with ethyl acetate (20 ml x 2 times) .
  • the organic phases are joined, anhydrified with sodium sulfate and concentrated at reduced pressure.
  • the raw product obtained is purifed by chromatography on silica gel eluating with hexane/ethyl acetate 9/1. 1.3 g of the desired product are obtained.
  • the mixture is diluted with water (20 ml) and extracted with ethyl acetate (20 ml x 2 times) .
  • the organic phases are joined, anhydrified with sodium sulfate and concentrated at reduced pressure.
  • the raw product obtained is purified by chromatography on silica gel eluating with hexane/ethyl acetate 9/1. 2.9 g of the desired product are obtained.
  • reaction mixture is kept under stirring at -10°C for about 20' , and a solution of methyl 2-bromopropionate (27.6 ml) in N,N-dimehylformamide (60 ml) is then added dropwise.
  • reaction mixture After 45' at a temperature ranging from -10°C to -5°C, the reaction mixture is diluted with acid water (200 ml) , bringing the pH to about 6, and extracted with ethyl acetate (100 ml x 2 times) .
  • the organic phases are joined, anhydrified with sodium sulfate and concentrated at reduced pressure.
  • the raw product obtained is purified by chromatography on silica gel eluating with hexane/ethyl acetate 99/1.
  • Leaves of vines (cultivar Dolcetto) , cultivated in vases in a conditioned environment (20 ⁇ 1°C, 70% relative humidity) are treated by spraying both sides of the leaves with compounds 1, 2 and 3, dispersed in a hydroacetone solution at 20% by volume of acetone.
  • the plants After remaining 24 hours in a conditioned environment, the plants are sprayed on both sides of the leaves with an aqueous suspension of conidia of Plasmopara viticola (20000 conidia per cm 3 ) .
  • the plants are kept in a humidity saturated environment at 21°C for the incubation period of the fungus .
  • the fungicidal activity is evaluated according to a percentage evaluation scale from 0 (completely infected plant) to 100 (healthy plant) . All the compounds tested showed a fungus control of over 90 at a concentration of 1000 ppm. EXAMPLE 9.
  • the plants After remaining 24 hours in a conditioned environment, the plants are sprayed on both sides of the leaves with an aqueous suspension of conidia of Erysiphe graminis (200000 conidia per cm 3 ) .
  • the plants are kept in a humidity saturated environment at a temperature ranging from 18 to 24°C for the incubation period of the fungus.
  • the fungicidal activity is evaluated according to a percentage evaluation scale from 0 (completely infected plant) to 100 (healthy plant) .
  • Leaves of wheat plants (cultivar Gemini) , cultivated in vases in a conditioned environment (20 ⁇ 1°C, 70% relative humidity) are treated by spraying both sides of the leaves with compounds 1, 2 and 3, dispersed in a hydroacetone solution at 20% by volume of acetone.
  • the plants After remaining 24 hours in a conditioned environment, the plants are sprayed on both sides of the leaves with an aqueous suspension of conidia of Puccinia recondita (200000 conidia per cm 3 ) .
  • the plants are kept in a humidity saturated environment at a temperature ranging from 18 to 24°C for the incubation period of the fungus.
  • the fungicidal activity is evaluated according to a percentage evaluation scale from 0 (completely infected plant) to 100 (healthy plant) . All the compounds tested showed a fungus control of over 90 at a concentration of 1000 ppm.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Compounds having general formula (I) are described, together with their use for the control of phytopathogenic fungi

Description

THIAZOLE DERIVATIVES WITH FUNGICIDAL ACTIVITY
The present invention relates to new thiazole derivatives.
More specifically, the present invention relates to new thiazole derivatives having high fungicidal activity, the process for their preparation, and their use for the control of phytopathogenic fungi, in particular in the agrarian field.
Strobilurines are fungal metabolites chemically characterized by the presence of the group 1- rαethoxycarbonyl-2-methoxyethen-l-yl ("Pesticide Science", 1991, page 499) .
They mainly act as inhibitors of mitochondrial respiration and have shown good control of the myceliar growth of various fungal species in tests in vi tro .
The presence of dienic or trienic systems in the molecular skeleton, however, makes these compounds unsuitable for practical use due to the high photochemical instability. The use of the thiazol-2-yl group in analogous products of strobilurines, having a good fungicidal activity with respect to phytopathogenic fungi, as described in patent application WO 9940076, is known in literature.
The Applicant has now found new analogous products of strobilurines, chemically characterized by the presence of a 4-thiazole group, having a good stability and surprisingly high fungicidal activity with respect to phytopathogenic fungi, together with a good selectivity towards the vegetables to which they are applied.
The object of the present invention therefore relates to compounds having general formula (I) :
(I) wherein:
Ri represents a hydrogen atom; a linear or branched Cι-C6 alkyl or haloalkyl group, optionally substituted; a C2-C6 alkenyl or haloalkenyl group, optionally substituted; a C2-
C6 alkynyl or haloalkynyl group, optionally substituted; a C3-C6 cycloalkyl group, optionally substituted; an aryl group, optionally substituted; a heteroaryl group, optionally substituted; a heterocyclic group, optionally substituted; a halogen atom; R2 represents a hydrogen atom; a halogen atom selected from chlorine, fluorine, bromine or iodine; a linear or branched Cι-C6 alkyl or haloalkyl group, optionally substituted; a linear or branched C2-C6 alkenyl or haloalkenyl group, optionally substituted; a linear or branched C2-C3 alkynyl or haloalkynyl group, optionally substituted; a C3-C6 cycloalkyl group, optionally substituted; a linear or branched Ci- C6 alkoxy or haloalkoxy group, optionally substituted; a linear or branched Cι-C6 alkylthio or haloalkylthio group, optionally substituted; a C3-C6 cycloalkoxy group, optionally substituted; a cyano group; a linear or branched C2-C8 alkoxycarbonyl group, optionally substituted; an aminocarbonyl group; a linear or branched C2-C8 alkylaminocarbonyl group; a linear or branched C3-Cι5 dialkylaminocarbonyl group; a linear or branched C2-C8 alkylcarbonyl group, optionally substituted; an aryl group, optionally substituted or a heteroaryl group, optionally substituted; a heterocyclic group, optionally substituted;
R3 and R4 independently represent a linear or branched C1-C4 alkyl group;
R5, the same or different when n is greater than or equal to 2, represents a halogen atom, optionally selected from fluorine, chlorine, bromine or iodine; a linear or branched Ci-Cβ haloalkyl group, optionally substituted; a linear or branched Cι-C6 alkoxy group, optionally substituted; a linear or branched Cι-C6 haloalkoxy group, optionally substituted; a linear or branched Cι-C6 alkylthio group, optionally substituted; a linear or branched Ci- C6 haloalkylthio group, optionally substituted; a C3-C6 cycloalkyl group optionally substituted; a linear or branched C2-C8 alkoxycarbonyl group; a cyano group; when Rx represents a linear or branched Cι-C6 haloalkyl group, substituted by at least two halogen atoms, the same or different, i.e. a linear or branched Cι-C6 polyhaloalkyl group, R5 also represents a linear or branched Ci-Ce alkyl group, optionally substituted; Y represents an oxygen atom; an NH group; Z represents a nitrogen atom or a CH group; n is a number ranging from 0 to 4. A further object of the present invention relates to the use of the compounds having general formula
(I)
(I) wherein:
Ri represents a hydrogen atom; a linear or branched Cι-C3 alkyl or haloalkyl group, optionally substituted; a C2-C6 alkenyl or haloalkenyl group, optionally substituted; a C2- C6 alkynyl or haloalkynyl group, optionally substituted; a C3-C6 cycloalkyl group, optionally substituted; an aryl group, optionally substituted; a heteroaryl group, optionally substituted; a heterocyclic group, optionally substituted; a halogen atom;
R2 represents a hydrogen atom; a halogen atom selected from chlorine, fluorine, bromine or iodine; a linear or branched Cχ-C6 alkyl or haloalkyl group, optionally substituted; a linear or branched C2-C6 alkenyl or haloalkenyl group, obtionally substituted; a linear or branched C2~C6 alkynyl or haloalkynyl group, optionally substituted; a C3-C6 cycloalkyl group, optionally substituted; a linear or branched Cι~ C6 alkoxy or haloalkoxy group, optionally substituted; a linear or branched Cι-C6 alkylthio or haloalkylthio group, optionally substituted; a C3-C6 cycloalkoxy group, optionally substituted; a cyano group; a linear or branched C2-C8 alkoxycarbonyl group, optionally substituted; an aird-nocarbonyl group; a linear or branched C2-C8 alkylaminocarbonyl group; a linear or branched C3-Cι5 dialkylaminocarbonyl group; a linear or branched C2-C8 alkylcarbonyl group, optionally substituted; an aryl group, optionally substituted, or heteroaryl group, optionally substituted; a heterocyclic group, optionally substituted; R3 and R4 independently represent a linear or branched C1-C4 alkyl group;
R5, the same or different when n is greater than or equal to 2, represents a halogen atom, optionally selected from fluorine, chlorine, bromine or iodine; a linear or branched Cι-C6 haloalkyl group, optionally substituted; a linear or branched Cι-C6 alkoxy group, optionally substituted; a linear or branched Cι-C6 haloalkoxy group, optionally substituted; a linear or branched Cι-C6 alkylthio group, optionally substituted; a linear or branched Ci- C6 haloalkylthio group, optionally substituted; a C3-C6 cycloalkyl group, optionally substituted; a linear or branched C2-C8 alkoxycarbonyl group; a cyano group; when Rx represents a linear or branched Cι-C6 haloalkyl group substituted by at least two halogen atoms, the same or different, i.e. a linear or branched Cχ-C6 polyhaloalkyl group, R5 also represents a linear or branched Cι-C6 alkyl group, optionally substituted; Y represents an oxygen atom; an NH group; Z represents a nitrogen atom or a CH group; n is a number ranging from 0 to 4, he control of phytopathogenic fungi. In particular, the use of the compounds having formula (I) for the control of phytopathogenic fungi is curative and/or preventive.
In the compounds having formula (I), the Ri group is preferably selected from a linear or branched Ci- C6 alkyl or haloalkyl group, optionally substituted; a C3^C6 cycloalkyl group, optionally substituted; an aryl group, optionally substituted; a heteroaryl group, optionally substituted. The R2 group is preferably selected from a hydrogen atom; a halogen atom; a linear or branched Ci-Ce alkyl or haloalkyl group, optionally substituted; a C3-C6 cycloalkyl group, optionally substituted; a linear or branched C2-C8 alkoxycarbonyl group, optionally substituted.
R3 and R4 are preferably equal to a methyl group, whereas R5 is preferably selected from a halogen atom, a Cι-C6 haloalkyl group or, when Ri represents a Ci-Cε haloalkyl group, R5 preferably represents a linear or branched Cι-C6 alkyl group, optionally substituted. n is preferably equal to 0 or 1, whereas Z is preferably equal to CH and Y is preferably an oxygen atom. A Cι-C6 alkyl group refers to a linear or branched Cι-C6 alkyl group.
Examples of this group are: methyl, ethyl propyl, isopropyl, butyl, isobutyl, tert-butyl. A Ci-Cβ haloalkyl group refers to a linear or branched alkyl group substituted by one or more halogen atoms, the same or different. In particular, a polyhaloalkyl group refers to a haloalkyl group substituted by at least two halogen atoms, the same or different.
Examples of this group are: fluoromethyl, chlorodifluoro ethyl, difluoromethyl, trifluoro- methyl, trichloro ethyl, 2, 2, 2-trifluoroethyl, 2,2,2- trichloroethyl, 1, 1, 2, 2, 2-pentafluoroethyl, 1,1,2,2- tetrafluoroethyl, 1, 2, 2, 2-tetrafluoroethyl, 2,2,3,3- tetrafluoropropyl, 2,2,3,3, 3-pentafluoropropyl .
A C2-C6 alkenyl group refers to a linear or branched C2-C6 alkenyl group.
Examples of this group are: ethenyl, propenyl, butenyl .
A C2-C6 haloalkenyl group refers to a linear or branched C2-C alkenyl group, substituted by one or more halogen atoms, the same or different.
Examples of this group are: 2, 2-dichloropropenyl, 1,2,2-trichloropropenyl. Examples of C2-C6 alkynyl groups are: ethynyl, propargyl .
A C2-C6 haloalkynyl group refers to a C2-C6 alkynyl group substituted by one or more halogen atoms, the same or different.
An example of a C2-C6 haloalkynyl group is: 3- chloropropynyl .
A C3-C6 cycloalkyl group refers to a cycloalkyl group whose ring consists of 3-6 carbon atoms, optionally substituted by one or more substituents, the same or different.
Examples of this group are: cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl.
A Cι~C6 alkoxy group refers to a Cι-C6 alkoxy group, wherein the aliphatic portion is a Cι-C6 alkyl group, as defined above.
Examples of this group are: methoxy, ethoxy.
A Cι-C6 haloalkoxy group refers to a Cι-C6 haloalkoxy group, wherein the aliphatic portion is a Cι-C6 haloalkyl group, as defined above.
Examples of this group are: trifluoromethoxy, 1,1,2, 2-tetrafluoroethoxy, 1,1,2,3,3, 3-hexafluoro- propyloxy. A Cι-C6 alkylthio group refers to a Cι-C3 alkylthio group, wherein the aliphatic portion is a Cι-C6 alkyl group, as defined above.
Examples of this group are: methylthio, ethylthio .
A Ci-Cβ haloalkylthio group refers to a Cι-C6 haloalkylthio group wherein the aliphatic portion is a Ci-Cε haloalkyl group, as defined above.
Examples of this group are: trifluoromethylthio, 1, 1,2, 2-tetrafluoroethylthio.
A C3-C6 cycloalkoxy group refers to a C3-C6 cycloalkoxy group wherein the aliphatic portion is a C3-C6 cycloalkyl group, as defined above.
Examples of this group are: cyclopentoxy, cyclohexyloxy.
A C2-C8 alkoxycarbonyl group refers to an alkoxycarbonyl group wherein the aliphatic portion is a Ci-C alkyl group, as defined above.
Examples of this group are: methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl .
A C2-C8 alkylaminocarbonyl or C3-Cι5 dialkylaminocarbonyl group refers to an alkylaminocarbonyl or dialkylaminocarbonyl group wherein the aliphatic portion is one or two Cι-C7 alkyl groups respectively, as defined above. Examples of this group are: N- methylaminocarbonyl, N,N-dimethylaminocarbonyl, N- isopropylaminocarbonyl, N-ethyl-N-methylaminocarbo- nyl. A C2-C8 alkylcarbonyl group refers to an alkylcarbonyl group wherein the aliphatic portion is a C1-C7 alkyl group, as defined above.
Examples of this group are: methylcarbonyl, ethylcarbonyl, isopropylcarbonyl . An aryl group refers to an aromatic carbocyclic group optionally substituted by one or more groups the same or different.
Examples of this group are: phenyl, naphthyl.
A heteroaryl group refers to an aromatic heterocyclic penta- or hexa-atomic group, also benzocondensed or heterobicyclic, containing from 1 to 4 hetero-atoms selected from nitrogen, oxygen, sulfur, optionally substituted by one or more groups, the same or different. Examples of heteroaryl groups are: pyridine, pyrimidine, pyridazine, pyrazine, triazine, tetrazine, quinoline, quinoxaline, quinazoline, furan, thiophene, pyrrole, oxazole, thiazole, isoxazole, isothiazole, oxadiazole, thiadiazole, pyrazole, imidazole, triazole, tetrazole, indole, benzofurane, benzothiophene, benzoxazole, benzothiazole, benzoxadiazole, benzothiadiazole, benzopyrazole, benzimidazole, benzotriazole, triazolopyridine, triazolopyrimidine, thiazolotriazo- le.
A heterocyclic group refers to a saturated or unsaturated ring with from three to twelve units, • containing at least one hetero-atom selected from nitrogen, oxygen, sulfur, optionally condensed with another aromatic or non-aromatic ring.
Examples of heterocyclic rings are: pyrrolidine, piperidine, dihydropiperidine, dihydropyridine, piperazine, morpholine, thiazine, indoline.
In the present invention, the term optionally or possibly substituted refers to a group which can have one or more substituents, the same or different, preferably selected from the following groups: halogen atoms possibly selected from chlorine, fluorine, bromine, iodine; Cι-C6 alkyl, alkoxy, alkylthio, in turn optionally substituted by halogen atoms; alkoxycarbonyl or alkylaminocarbonyl optionally halogenated; aminocarbonyl; C2-Ca dialkylaminocarbonyl optionally halogenated; C2-C8 alkylcarbonyl; C2-C8 alkylcarbonyloxy; cyano; nitro; formyl; hydroxy; amino; carboxy. As already mentioned, the compounds having formula (I) have high fungicidal activity.
Examples of compounds having formula (I) which are interesting for their activity are: • methyl (E) -3-methoxy-2-{2- [2- (trifluoromethyl) -5- methylthiazol-4-yloxymethyl]phenyl}acrylate;
• methyl (E) -2-methoxyimino-2-{2- [2- (trifluoro- methyl) -5-methylthiazol-4-yloxymethyl]phenyl }- acetate; • N-methyl- (E) -2-methoxyimino-2-{2- [2- (trifluorome- thyl) -5-methylthiazol-4-yloxymethyl] henyl}- acetamide;
• methyl (E) -3-methoxy-2-{2- [2- (1, 1, 2, 2, 2-penta- fluoroethyl) -5-methylthiazol-4-yloxymethyl] - phenyl}acrylate;
• N-methyl- (E) -2-methoxyimino-2-{2- [2- (1, 1, 2, 2, 2- pentafluoroethyl) -5-methylthiazol-4-yloxymethyl- phenyl }acetamide;
• methyl (E) -3-methoxy-2-{2- [2- (1, 1, 2, 2-tetra- fluoroethyl) -5-methylthiazol-4-yloxymethyl] - phenyl }acrylate;
• methyl (E) -2-methoxyimino-2-{2- [2- (1, 1, 2, 2, 2- pentafluoro-ethyl) -5-methylthiazol-4-yloxymethyl] - phenyl}acetate; • methyl (E) -3-methoxy-2-{2- [2- (1, 2, 2, 2-tetrafluoro- ethyl) -5-methylthiazol-4-yloxymethyl]phenyl}- acrylate;
• N-methyl- (E) -2-methoxyimino-2-{2- [2- (1, 1,2,2- tetrafluoroethyl) thiazol-4-yloxymethyl]phenyl}- acetamide;
• methyl (E) -3-methoxy-2-{2- [2- (2, 2, 2-trifluoro- ethyl) -5~methylthiazol-4-yloxymethyl] phenyl}- acrylate; • methyl (E) -2-methoxyimino-2-{2- [2- (1, 1, 2, 2-tetra- fluoroethyl) -5-methylthiazol-4-yloxymethyl] - phenyl }acetate;
• N-methyl- (E) -2-methoxyimino-2-{2- [2- (1,2, 2,2- tetrafluoroethyl) -5-methyl-thiazol-4-yloxymethyl] phenyl }acetamide;
• methyl (E) -3-methoxy-2-{2- [2- (trifluoromethyl) - thiazol-4-yloxymethyl] phenyl}acrylate;
• methyl (E) -3-methoxy-2-{2- [2- (trifluoromethyl) -5- chlorothiazol-4-yloxymethyl]phenyl}acrylate; • N-methyl-(E)-2-methoxyimino-2-{2-[2-(2,2,2- trifluoroethyl) -5-methyl-thiazol-4-yloxymethyl] phenyl}acetamide;
• N-methyl- (E) -2-methoxyimino-2-{2- [2- (trifluoromethyl) -5-ethylthiazol-4-yloxymethyl] phenyl }- acetamide; • methyl (E) -2-methoxyimino-2-{2- [2- (1, 2, 2,2- tetrafluoro-ethyl) -5-methylthiazol-4-yloxymethyl] - phenyl}acetate;
• methyl (E) -2-methoxyimino-2-{2- [2- (2,2,2- trifluoroethyl) -5-methylthiazol-4-yloxymethyl] - phenyl}acetate;
• methyl (E) -3-methoxy-2-{2- [2- (trifluoromethyl) -5- ethylthiazol-4-yloxymethyl]phenyl} acrylate;
• methyl (E) -3-metoxy-2-{2- [2- (trifluoromethyl) -5- cyclopropylthiazol-4-yloxymethyl]phenyl} acrylate;
• methyl (E) -3-methoxy-2-{2- [2- (difluoromethyl) -5- methylthiazol-4-yloxymethyl] phenyl}acrylate;
• N-methyl- (E) -2-methoxyimino-2-{2- [2- (difluoro- methyl) -5-methylthiazol-4-yloxymethyl] phenyl} acetamide;
• methyl (E) -3-methoxy-2-{2- [2- (chlorodifluoro- methyl) -5-methylthiazol-4-yloxymethyl] phenyl } - acrylate;
• N-methyl- (E) -2-methoxyimino-2- {2- [2- (chloro- difluoromethyl) -5-methylthiazol-4-yloxymethyl] - phenyl }acetamide;
• methyl (E) -3-methoxy-2- [2- (2- (pyridin-2-yl) -5- methylthiazol-4-yloxymethyl) phenyl] acrylate;
• methyl (E) -2-metoxyimino-2- [2- (2- (pyridin-2-yl) -5- methylthiazol-4-yloxymethyl) phenyl] acetate; • N-methyl- (E) -2-methoxyimino-2- [2- (2- (pyridin-2- yl) -5-methylthiazol-4-yloxymethyl) phenyl] acetamide;
• methyl (E) -3-methoxy-2- [2- (2- (pyridin-3-yl) -5- methyl-thiazol-4-yloxymethyl) phenyl] acrylate;
• N-methyl- (E) -2-methoxyimino-2- [2- (2- (pyridin-3- yl) -5-methylthiazol-4-yloxymethyl) phenyl] - acetamide;
• methyl (E) -3-methoxy-2- [2- (2- (pyridin-4-yl) -5- methylthiazol-4-yloxymethyl) phenyl] acrylate;
• N-methyl- (E) -2-methoxyimino-2- [2- (2- (pyridin-4- yl) -5-methylthiazol-4-yloxymethyl) phenyl] - acetamide;
• methyl (E) -3-methoxy-2- [2- (2- (4-chlorophenyl) -5- methylthiazol-4-yloxymethyl) phenyl] acrylate;
• N-methyl- (E) -2-methoxyimino-2- [2- (2- (2, 6- difluorophenyl) thiazol-4-yloxymethyl) phenyl] - acetamide;
• methyl (E) -3-methoxy-2- [2- (2-cyclopropyl-5-methyl- thiazol-4-yloxymethyl) phenyl] acrylate;
• methyl (E) -2-methoxyimino-2- [2- (2- (2-fluoro- phenyl) -5-methylthiazol-4~yloxymethyl) -phenyl] - acetate;
• N-methyl- (E) -2-methoxyimino-2- [2- (2- (2-propyl) -5- methylthiazol-4-yloxymethyl) phenyl] acetamide; • methyl (E) -3-methoxy-2- [2- (2- (pyridin-2-yl) - thiazol-4-yloxymethyl) phenyl] acrylate;
• methyl (E) -3-methoxy-2- [2- (2- (pyridin-2-yl) -5- trifluoromethylthiazol-4-yloxymethyl) phenyl] - acrylate;
• N-methyl- (E) -2-methoxyimino-2- [2- (2-phenyl-5-
(methoxycarbonyl) thiazol-4-yloxymethyl) phenyl] - acetamide;
• N-methyl- (E) -2-methoxyimino-2- [2- (2- (4-methyl- phenyl) ~5-cyano-thiazol-4~yloxymethyl) phenyl] - acetamide;
• methyl (E) -3-methoxy-2- [2- (2- (4-trifluoromethyl- phenyl) -5-cyclopropylthiazol-4-yloxymethyl) - phenyl] acrylate; • methyl (E) -3-methoxy-2- [2- (2- (2, 4-dichlorophenyl) - 5-methoxythiazol-4-yloxymethyl) phenyl] acrylate.
A further object of the present invention relates to the processes for the preparation of the compounds having general formula (I) . The compounds having general formula (I) can be obtained by the condensation of a compound having general formula (II) with a thiazolyl derivative having general formula (III) , according to reaction scheme A: Scheme A
( ii ) ( III ) ( I )
wherein Rx, R2, R3, R4 R5, Y Z and n have the meanings defined above, L represents a leaving group such as a chlorine atom, a bromine atom, an RS03 ~ group wherein R represents a Cι-C6 alkyl or haloalkyl or a phenyl optionally substituted.
The reaction can be conveniently carried out in an inert organic solvent, at a temperature ranging from 0°C to the boiling point of the reaction mixture, optionally in the presence of an inorganic or organic base.
Preferred solvents for the reaction are: alcohols (methanol, ethanol, propanol, methoxyethanol etc.); ethers (ethyl ether, isopropyl ether, tetrahydrofuran, dioxane, dimethoxyethane, etc.); esters (ethyl acetate, etc.); ketones (acetone, methylethylketone etc.); chlorinated hydrocarbons (methylene chloride, dichloroethane, chloroform, carbon tetrachloride, etc.); aromatic hydrocarbons
(benzene, toluene, xylene, etc.); aliphatic hydrocarbons (hexane, heptane, cyclohexane, etc.); dipolar aprotic solvents ( N,N-dimethylformamide, dimethylsulfoxide, sulfolane, etc.).
Preferred inorganic bases are: hydrides, hydroxides, carbonates of alkaline or earth-alkaline metals (sodium, potassium, calcium, etc.).
Preferred organic bases are: pyridine, dimethylaminopyridine, aliphatic amines, (diethyl- amine, triethylamine, etc.), cyclic amines (morpholine, piperidine, diazabicycloundecene, etc.); alcoholates of alkaline metals (potassium t-butylato, etc. ) . The compounds having general formula (I), wherein Z is N and Y is NH, can be alternatively obtained by the reaction of the corresponding compound having formula (I) wherein Z is N and Y is 0 with a suitable a ine having the formula R4NH2 wherein R4 has the meanings defined above.
The reaction can be conveniently carried out in an inert organic solvent, at a temperature ranging from 0°C to the boiling point of the reaction mixture . Preferred solvents for the reaction are: alcohols (methanol, ethanol, propanol, methoxyethanol, etc.); ethers (ethyl ether, isopropyl ether, tetrahydrofuran, dioxane, dimethoxyethane, etc.); ketones (acetone methylethylketone etc.); chlorinated hydrocarbons (methylene chloride, dichloroethane, chloroform, carbon tetrachloride etc.); aromatic hydrocarbons (benzene, toluene, xylene, etc.); aliphatic hydrocarbons (hexane, heptane cyclohexane, etc.); dipolar aprotic solvents (N,N- dimethylformamide, dimethylsulfoxide, sulfolane, etc.); or mixtures of these in any ratio.
The compounds having general formula (I) have isomerism on the double bond R4YCO-C=Z-OR3; the object of the present invention also includes the use of the compounds having formula (I) as isomeric mixtures in any proportion, and also the formation and use of the single isomers E or Z of the compounds having formula (I) . For the purposes of the fungicidal activity, however, isomers E of the compounds having formula (I) are preferred, and consequently the use of isomers E of the compounds having formula (I), is also preferred.
The intermediates having general formula (II) are known compounds . The thiazoles having general formula (III) , when not known as such, can be prepared by means of the methods known in literature, according to what is described, for example, in: Journal of Medicinal Chemistry 1991, vol.34, pages 2158-2165.
The thiazoles having general formula (III) wherein Ri has the meaning of a linear or branched Cx-Cβ polyhaloalkyl group are new compounds .
A further object of the present invention therefore relates to compounds having general formula (III') :
(III') wherein Ri' represents a linear or branched Cι-C6 polyhaloalkyl group and R2' has the same meaning as R2 and their use as intermediates for the preparation of compounds useful both in the agrochemical and pharmaceutical field. A Cι-C6 polyhaloalkyl group refers to a linear or branched Cι-C6 alkyl group substituted by at least two halogen atoms, the same or different. In particular, the group Ri' is selected from trifluoromethyl, difluoromethyl, chlorodifluoro- methyl, 2, 2, 2-trifluoroethyl, 2, 2, 3, 3-tetrafluoropropyl, 2,2, 3,3, 3-pentafluoropropyl, 1,1,2,2,2- pentafluoroethyl, 1, 2, 2, 2-tetrafluoroethyl, 1,1,2,2- tetrafluoroethyl .
The group R2' is preferably selected from a hydrogen atom, a halogen atom, a linear or branched Cι-C6 alkyl or haloalkyl group, optionally substituted, a C3-C6 cycloalkyl group, optionally substituted; an aryl group, optionally substituted; a heteroaryl group, optionally substituted; a cyano group; a linear or branched C2-C8 alkoxycarbonyl group, optionally substituted. The compounds having formula (III' ) can also exist in a tautomeric ketonic form (IV), and also in mixtures between the two forms (III') e (IV) .
(IN)
Examples of the intermediates having formula (III') of particular interest are: 2- (trifluoromethyl) -4-hydroxy-5-methylthiazole;
2- (trifluoromethyl) -4-hydroxy-5-chlorothiazole;
2- (trifluoromethyl) -4-hydroxythiazole;
2- (trifluoromethyl) -4-hydroxy-5-cyclopropylthiazole; 2- (trifluoromethyl) -4-hydroxy-5- (2-pyridyl) thiazole;
2- (trifluoromethyl) -4-hydroxy-5- (dichlorophenyl) - thiazole;
2- (trifluoromethyl) -4-hydroxy-5-cyanothiazole;
2- (1, 1, 2, 2, 2-pentafluoroethyl) -4-hydroxy-5-methyl- thiazole;
2- (1, 1, 2, 2, 2-pentafluoroethyl) -4-hydroxy-5- phenylthiazole;
2- (1, 1, 2, 2, 2-pentafluoroethyl) -4-hydroxythiazole;
2- (2, 2, 2-trifluoroethyl) -4-hydroxy-5-methylthiazole; 2- (2, 2, 2-trifluoroethyl) -4-hydroxythiazole;
2- (1,2, 2, 2-tetrafluoroethyl) -4-hydroxy-5-methyl- thiazole;
2- (1,2,2, 2-tetrafluoroethyl) -4-hydroxythiazole;
2- (1, 1, 2, 2-tetrafluoroethyl) -4-hydroxy-5-methylthia- zole;
2- (1, 1, 2, 2-tetrafluoroethyl) -4-hydroxy-5-phenylthiazole;
2- (1, 1,2, 2-tetrafluoroethyl) -4-hydroxythiazole;
2- (difluoromethyl) -4-hydroxy-5-methylthiazole; 2- (difluoromethyl) -4-hydroxythiazole; 2- (difluoromethyl) -4-hydroxy-5-cyclopentylthiazole; 2- (chlorodifluoromethyl) -4-hydroxy-5-methylthiazole; 2- (chlorodifluoromethyl) -4-hydroxythiazole; 2- (trifluoromethyl) -4-hydroxy-5-phenylthiazole; 2- (trifluoromethyl) -4-hydroxy-5-ethoxycarbonyl- thiazole.
It is also known from the chemical literature relating to 4-hydroxythiazoles that in polar solvents such as dimethylsulfoxide, N,N-dimethylformairu.de, the prevalent form is hydroxylic (III'), according to what is described, for example, in: Comprehensive Heterocyclic Chemistry, vol. 6, pages 248-249.
A further object of the present invention relates to the processes for the preparation of the compounds having general formula (III').
The compounds having general formula (III') can be obtained by the condensation of a thioamide having formula (V) with a derivative having formula (VI), according to reaction scheme B:
(V) (VI) (III')
Scheme B wherein Ri' and R2' have the meanings defined above, X represents a leaving group such as a chlorine atom, a bromine atom, a RS0~ group, W represents an OR group, wherein R has the meaning of a linear or branched Cι-C6 alkyl or haloalkyl or phenyl, optionally substituted; or a halogen atom; or an H2 group.
The reaction can be conveniently carried out in an inert organic solvent, at a temperature ranging from -70°C to the boiling point of the reaction mixture, optionally in the presence of an inorganic or organic base.
Preferred solvents for the reaction are: aromatic hydrocarbons (benzene, toluene, xylene, etc.); aliphatic hydrocarbons (hexane, heptane, cyclohexane, etc.); alcohols (methanol, ethanol, etc.); ethers (ethyl ether, isopropyl ether, tetrahydrofuran, dioxane, dimethoxyethane, etc.); esters (ethyl acetate, etc.); ketones (acetone, methylethylketone, etc.); chlorinated hydrocarbons (methylene chloride, dichloroethane, chloroform, carbon tetrachloride, etc.); dipolar aprotic solvents (N,N-dimethylformamide, dimethylsulfoxide, sulfolane, etc. ) . Preferred inorganic bases are: hydrides, hydroxides, carbonates of alkaline and earth-alkaline metals (sodium, potassium, calcium, etc.).
Preferred organic bases are: pyridine, dimethylaminopyridine, aliphatic amines, (diethylamine, triethylamine, etc.), cyclic amines (morpholine, piperidine, diazabicycloundecene, etc.); alcoholates of alkaline metals (potassium t-butylate, etc. ) . The thioamides having general formula (V) , when they are not known as such, can be prepared by means of the methods known in literature, according to what is described, for example, in : Houben-Weil Band E5 / Teil 1 (pages 1218-1277) . The intermediates having general formula (VI) are compounds known in literature, for example, in: Journal American Chemical Society (1944), vol.66, page 2074; Synthesis (1969), page 39.
Alternatively, the compounds having general formula (III') can be obtained by condensation between a nitrile having formula (VII) and a carboxylic derivative having formula (VIII) according to reaction scheme C:
(VII) (VIII) (III')
Scheme C wherein Ri' and R2' have the meanings defined above, T represents an OH group or an OR group wherein R has the meaning of a linear or branched d.-
Cs alkyl or haloalkyl, or phenyl optionally substituted.
The reaction can be conveniently carried out in the presence of or in the absence of an inert organic solvent, at a temperature ranging from ~70°C to the boiling point of the reaction mixture, optionally in the presence of an inorganic or organic base or alternatively in the presence of an inorganic or organic acid.
Preferred solvents for the reaction are: aromatic hydrocarbons (benzene, toluene, xylene, etc.); aliphatic hydrocarbons (hexane, heptane, cyclohexane, etc.); alcohols (methanol, ethanol, ecc.) ; ethers (ethyl ether, isopropyl ether, tetrahydrofuran, dioxane, dimethoxyethane, etc.); esters (ethyl acetate, etc.); ketones (acetone, methylethylketone, etc.); chlorinated hydrocarbons (methylene chloride, dichloroethane, chloroform, carbon tetrachloride, etc.); dipolar aprotic solvents (N,N-dimethylformamide, dimethylsulfoxide, sulfolane, etc. ) . Preferred inorganic bases are: hydroxides, carbonates of alkaline or earth-alkaline metals (sodium, potassium, calcium, etc.).
Preferred organic bases are: pyridine, dimethylaminopyridine, aliphatic amines, (diethyl- amine, triethylamine, etc.), cyclic amines
( orpholine, piperidine, diazabicycloundecene, etc.); alcoholates of alkaline metals (potassium t-butylate, etc. ) .
Preferred inorganic acids are: hydrochloric acid, sulfuric acid, etc.
Preferred organic acids are: acetic acid, citric acid, etc.
The nitriles having general formula (VII) and the carboxylic derivatives having general formula (VIII) , when they are not known as such, can be prepared by means of the methods known in literature, for example, according to what is described in Journal American Chemical Society (1943), vol.65, page 1459. The compounds having general formula (I) have a particularly high fungicidal activity against phytopathogenic fungi which attack vines, sugar beet, cereals, vegetables, rice, Cucurbitaceae, fruit trees.
Examples of phytopathogenic fungi which can be effectively fought with the compounds having general formula (I) are:
Helminthosporium spp. on cereals; - Erysiphe spp. on cereals; Puccinia spp. on cereals; Plasmopara viticola on vines; Pythium spp. on vegetables; Phytophthora spp. on vegetables; - Rhynchosporiu on cereals; Septoria spp. on cereals;
Sphaerotheca fuliginea on Cucurbitaceae (for example cucumbers) ;
Podosphaera leucotricha on apple-trees; - Pyricularia oryzae on rice; Uncinula necator on vines; Ventυria spp. on fruit trees; Botrytls cinerea on vines and vegetables; Fusarium spp. on cereals; - Al ternaria spp. on fruit trees and vegetables; Cercospora spp. on sugar beet. The compounds having general formula (I) are capable of exerting a fungicidal action of both a curative and preventive nature and have a low or non- existing phytotoxicity.
Many groups of the compounds having general formula (I) also have a collateral insecticidal and acaricidal activity.
An object of the present invention therefore also relates to the use of the compounds having general formula (I) as insecticides and/or acaricides.
A further object of the present invention consequently relates to a method for the control of phytopathogenic fungi in agricultural crops by the application of the compounds having general formula
(I) •
The quantity of compound to be applied to obtain the desired effect can vary in relation to various factors such as, for example, the compound used, the crop to be preserved, the type of pathogen, the degree of infection, the climatic conditions, the method of application, the formulation adopted.
Doses of compound ranging from 10 g to 5 kg per hectare generally provide a sufficient control . For practical uses in agriculture it is often useful to adopt fungicidal compositions containing one or more compounds having general formula (I) .
The application of these compositions or compounds having formula (I) can be effected on any part of the plant, for example on the leaves, stems, branches and roots, or on the seeds themselves before sowing, or on the ground in which the plant grows .
Compositions can be used in the form of dry powders, wettable powders, emulsifiable concentrates, micro-emulsions, pastes, granulates, solutions, suspensions, etc.: the choice of the type of composition will depend on the specific use.
The compositions are prepared in the known way, for example by diluting or dissolving the active substance with a solvent medium and/or a solid diluent, optionally in the presence of surface-active agents .
Solid diluents, or carriers which can be used, are, for example: silica, kaolin, bentonite, talc, fossil flour, dolomite, calcium carbonate, magnesia, chalk, clays, synthetic silicates, attapulgite, seppiolite.
Liquid diluents which can be used are, for example, in addition to water, aromatic organic solvents (xylols or alkyl benzene mixtures, chlorobenzene, etc.), paraffins (oil fractions), alcohols (methanol, propanol, butanol, octanol, glycerine, etc.), esters (ethyl acetate, isobutyl acetate etc.), ketones (cyclohexanone, acetone, acetophenone, isophorone, ethylamylketone, etc.), amides (N,N-dimethylformamide, N-methylpyrrolidone, etc. ) .
Surface-active agents which can be used are salts of sodium, calcium, triethylamines or triethanolamines, alkylsulfonates, alkylaryl- sulfonates, polyethoxylated alkylphenols, poly- ethoxylated esters of sorbitol, ligninsulfonates, etc. The compositions can also contain special additives for particular purposes, for example adhesion agents such as arabic rubber, polyvinyl alcohol , polyvinylpyrrolidone, etc..
If desired, it is possible to add other active principles to the compositions, compatible with the compounds having general formula (I), such as for example other fungicides, phytoregulators, antibiotics, herbicides, insecticides, fertilizers.
Examples of other fungicides which can be included in the compositions of the invention are: AC-382042, acibenzolar, ampropylphos, anilazine, azaconazole, azoxystrobin, benalaxyl (in its racemic form or as an optically active R isomer) , benclothiaz, beno yl, bitertanol, blasticidin-S, bromuconazole, bupirimate, buthiobate, captafol, captan, carbendazim, carboxin, carpropamid, chinomethionat, chloroneb, chlorothalonil, chlozolinate, cyazofamid, cymoxanil, cyproconazole, cyprodinil, debacarb, dichlofluanid, dichlone, dichlobutrazol, dichlomezine, dichloran, dicyclomet, diethofencarb, diphenoconazole, diflumetorim, dimethirimol, dimethomorph, diniconazole, dinocap, a fungicide dipeptide, dipyrithione, ditalimphos, dithianon, dodemorph, dodine, edifenphos, epoxiconazole, etaconazole, ethaboxam, ethirimol, ethoxyquin, etridiazole, famoxadone, fenamidone, fenaminosulf, fenapanyl, fenarimol, fenbuconazole, fenfuram, fenhexamid, fenpiclonyl, fenpropidin, fenpropimorph, fentin, ferbam, ferimzone, fluazinam, fludioxonyl, flumetover, flumorph, fluoroimide, fluotrimazole, fluoxastrobin, fluquinconazole, flusilazole, flusulfamide, flutolanil, flutriafol, folpet, fosetylaluminium, fuberidazole, furalaxyl, furconazole, guazatine, hexaconazole, hydroxyquinoline sulfate, hymexazol, ICIA0858, imazalil, imibenconazole, iminoctadine, ipconazole, iprobenphos, iprodione, isoprothiolane, iprovalicarb, kasugamycin, kresoxim-methyl, mancopper, mancozeb, maneb, mebenil, mepanipyrim, mepronil, metalaxyl, metalaxyl-M, metconazole, methfuroxam, metiram, etsulfovax, MON-65500, myclobutanil, natamycin, nitrothal-isopropyl, nuarimol, ofurace, orisastrobin, oxadixyl, oxycarboxin, pefurazoate, penconazole, pencycuron, pentachlorophenol and its salts, phthalide, piperalin, Bordeaux mixture, polyoxins, probenazole, prochloraz, procymidone, propamocarb, propiconazole, propineb, proquinazid, prothiocarb, prothioconazole, pycoxystrobin, pyracarbolid, pyrachlostrobin, pyrazophos, pyrifenox, pyrimethanil, pyroquilon, pyroxyfur, quinacetol, quinazamid, quinconazole, quinoxyfen, quintozene, rabenazole, cuprum hydroxyde, cuprum oxychloride, cuprum sulfate, RH-7281, RPA-407213, simeconazole, spiroxamine, spiromesifen, SSF-126 (metominostrobin) , streptomycin, SYP-L-190, tebuconazole, tetraconazole, thiabendazole, thicyofen, thifluzamide, thiophanate- methyl, thiram, tioxymid, tolclofos-methyl, tolylfluanid, triadimefon, triadimenol, triarimol, triazbutil, triazoxide, tricyclazole, tride orf, trifloxystrobin (CGA 279202), triflumizole, triforine, triticonazole, validamycin, vinclozolin, zineb, zira , sulfur, zoxamide.
These fungicidal compounds are commercial compounds or compounds about to be commercialized. Their description can be easily found in technical literature, for example in "The pesticide manual", 2000, XII edition, British Crop Protection Council Ed.
Dipeptide with a fungicidal activity refers to one of the compounds among those claimed in patent application EP-A-1028125.
The concentration of active principle in the above compositions can vary within a wide range depending on the active compound, the applications for which they are destined, the environmental conditions and type of formulation adopted.
The concentration of active principle generally ranges from 1% to 90%, preferably from 5 to 50%.
The following examples are provided as an illustration of the present invention, but should in no way be considered as limiting the scope of the invention itself. EXAMPLE 1. Preparation of methyl (E) -3-methoxy-2-{2- [2- (trifluoromethyl) -5-methylthiazol-4-yloxymethyl] - phenyl}acrylate. (Compound Nr.l)
A solution of methyl (E) -3-methoxy-2- (2- bromomethylphenyl) acrylate (19.8 g) in N,N- dimethylformamide (50 ml) is added at room temperature to a solution of 2- (trifluoromethyl) -4- hydroxy-5-methylthiazole (14.1 g) in N,N- dimethylformamide (50 ml) containing potassium carbonate (10.6 g) .
After stirring overnight, the reaction mixture is diluted with water (200 ml) and extracted with ethyl acetate (100 ml x 2 times) .
The organic phases are joined, washed with water (100 ml x 3 times), anhydrified with sodium sulfate and concentrated at reduced pressure .
The raw product obtained is purified by chromatography on silica gel eluating with hexane/ethyl acetate 19/1. 23 g of the desired product are obtained. M.p.= 59°C
XH-NMR (δ-ppm, CDC13) = 2.25 (s, 3H) ; 3.15 (s, 3H) ; 3.3 (s 3H) ; 5.25 (s, 2H) ; 7.1-7.6 (m, 5H) . GC- MS: 387 (M+) . EXAMPLE 2. Preparation of methyl (E) -3-methoxy-2- [2- (2- (pyridin-2-yl) -5-methylthiazol-4-yloxymethyl) phenyl] - acrylate. (Compound Nr. 2)
A solution of 2- (pyridin-2-yl) -4-hydroxy-5- methylthiazole (0.77 g) in N,N-dimethy1formamide (5 ml) is added dropwise to a suspension of sodium hydride (0.16 g) in N,N-dimethylformamide (5 ml).
After 30', a solution of methyl (E) -3-methoxy-2-
(2-bromomethylphenyl) acrylate (1.5 g) in N,N- dimethylformamide (5 ml) is added to the reaction mixture, maintained under stirring and at room temperature.
After 4 hours at room temperature, the mixture is diluted with water (20 ml) and extracted with ethyl acetate (20 ml x 2 times) . The organic phases are joined, anhydrified with sodium sulfate and concentrated at reduced pressure. The raw product obtained is purifed by chromatography on silica gel eluating with hexane/ethyl acetate 9/1. 1.3 g of the desired product are obtained.
^H-NMR (δ-ppm, CDC13) = 2.3 (s, 3H) ; 3.7 (s, 3H) ; 3.9 (s, 3H) ; 5.3 (s, 2H) ; 7-7.8 (m, 7H) ; 8.1 (dd, IH) ; 8.6(dd, IH) . EXAMPLE 3. Preparation of methyl (E) -2-methoxyimino-2- [2- (2- (pyridin-2-yl) -5-methylthiazol-4-yloxymethyl) - phenyl] acetate. (Compound Nr. 3) .
A solution of 2- (pyridin-2-yl) -4-hydroxy-5- methylthiazole (1.55 g) in N,N-dimethylformamide (10 ml) is added dropwise to a suspension of sodium hydride (0.32 g) in N,N-dimethylformamide (12 ml).
After 30', a solution of methyl (E)-2- methoxyimino-2- (2-bromomethylphenyl) acetate (3.1 g) in N,N-dimethylformamide (15 ml) is added to the reaction mixture, maintained under stirring and at room temperature.
After 4 hours at room temperature, the mixture is diluted with water (20 ml) and extracted with ethyl acetate (20 ml x 2 times) . The organic phases are joined, anhydrified with sodium sulfate and concentrated at reduced pressure. The raw product obtained is purified by chromatography on silica gel eluating with hexane/ethyl acetate 9/1. 2.9 g of the desired product are obtained.
^-NMR (δ-ppm, CDC13) = 2.3 (s, 3H) ; 3.8 (s, 3H) ; 3.95 (s, 3H) ; 5.3 (s, 2H) ; 7-7.8 (m, 6H) ; 8.1 (dd, IH) ; 8.6(dd, IH) . EXAMPLE 4. Preparation of N-methyl- (E) -2-methoxyimino-2- [2- (2- (pyridin-2-yl) -5-methylthiazol-4-yloxymethyl) - phenyl] acetamide. (Compound Nr. 4)
An aqueous solution at 40% of N-methylamine (1.2 ml) is added to a solution of methyl (E)-2- methoxyimino-2- [2- (2- (pyridin-2-yl) -5-methylthiazol- 4-yloxymethyl) phenyl] acetate (Compound Nr. 3; 1.5 g) in N,N-dimethylformamide and methanol in a ratio of 1:2 (9 ml). The mixture is left under stirring for 2 hours at room temperature, diluted with water and extracted with ethyl acetate (20 ml x 2) . The organic phases are joined, washed with water (30 ml x 2), anhydrified with sodium sulfate and concentrated at reduced pressure. 1.4 g of raw product are obtained, which does not require further purification.
XH-NMR (δ-ppm, CDC13) = 2.3 (s, 3H) ; 3.45 (d, 3H) ; 3.85 (s, 3H) ; 5.3 (s, 2H) ; 7-7.8 (m, 6H) ; 8.1 (dd, IH) ; 8.6(dd, IH) .
Operating analogously to what is described in the previous examples, the compounds indicated in Table 1 below, were prepared. Table 1.
EXAMPLE 5
Preparation of 2- (trifluoromethyl) -4-hydroxy-5- ethylthiazole. (Reaction scheme B; compound (III')-l) A solution of trifluorothioaceta ide (35.5 g) in N,N-dimethylformamide (60 ml) is added dropwise to a suspension of sodium hydride at 60% (11 g) in N,N- dimethylformamide (60 ml), the temperature being maintained at -10°C .
At the end of the addition, the reaction mixture is kept under stirring at -10°C for about 20' , and a solution of methyl 2-bromopropionate (27.6 ml) in N,N-dimehylformamide (60 ml) is then added dropwise.
After 45' at a temperature ranging from -10°C to -5°C, the reaction mixture is diluted with acid water (200 ml) , bringing the pH to about 6, and extracted with ethyl acetate (100 ml x 2 times) .
The organic phases are joined, washed with water
(100 ml x 3 times) , anhydrified with sodium sulfate and concentrated at reduced pressure. The raw product obtained is purified by chromatography on silica gel eluating with hexane/ethyil acetate 99/1. 25 g of the desired product are obtained.
M.p.= 108-110°C
^- MR (δ-ppm, DMSO) = 2.3 (s, 3H) ; 10.4 (s, IH) .
GC-MS: 183 (M+) . Elemental analysis [% found (theoretical) ]=
C 32.85 (32.79); H 2.10.(2.18); N 7.45 (7.65). EXAMPLE 6
Preparation of 2- (trifluoromethyl) -4-hydroxy-5- methylthiazole. (Reaction scheme C; compound (III')-l) Trifluoroacetonitrile (11.8 g) is condensed in a solution of thiolactic acid (13.1 g) and pyridine (2.5 ml) in tetrahydrofuran (120 ml) mantained at -70°C and the mixture is kept under stirring at this temperature for about an hour. The reaction mixture is gradually brought to room temperature and is then heated to reflux temperature for an hour.
It is cooled, the solvent is evaporated, water is added (50 ml) to the reaction raw product and the mixture is extracted with ethyl acetate (50 ml x 2 times) .
The organic phases are joined, anhydrified with sodium sulfate and concentrated at reduced pressure. The raw product obtained is purified by chromatography on silica gel eluating with hexane/ethyl acetate 99/1.
15.5 g of the desired product are obtained. M.p.= 108-110°C -NMR (δ-ppm, DMSO) = 2.3 (s, 3H) ; 10.4 (s, IH) . GC-MS: 183 (M+) .
Elemental analysis [% found (theoretical) ]= C 31.95 (32.79); H 2.02.(2.18); N 7.93 (7.65). EXAMPLE 7
Preparation of 2- (pyridin-2-yl) -4-hydroxy-5- methylthiazole . (Reaction scheme C) .
1.9 g of pyridine are added dropwise to a mixture of thiolactic acid (10.2 g) and 2-cyanopyridine (10 g) , and the mixture is heated to 100°C for 2 hours.
After cooling, ethanol is added and the precipitate formed is filtered; the solid is recrystallized from ethyl ether and dried. 15.5 g of product are obtained. ^-H-NMR (δ-ppm, DMS0- 6) : 2.25 (s, 3H) ; 7.35-7.6
(m, 2H) ; 8.05-8.35 (m, 2H) ; 10.5 (bs, IH) .
Operating analogously to what is described in the previous examples, the intermediates indicated in Table 2 below, were prepared Table 2.
EXAMPLE 8.
Determination of the fungicidal activity against vine mildew [Plasmopara viticola) .
Leaves of vines (cultivar Dolcetto) , cultivated in vases in a conditioned environment (20±1°C, 70% relative humidity) are treated by spraying both sides of the leaves with compounds 1, 2 and 3, dispersed in a hydroacetone solution at 20% by volume of acetone.
After remaining 24 hours in a conditioned environment, the plants are sprayed on both sides of the leaves with an aqueous suspension of conidia of Plasmopara viticola (20000 conidia per cm3) .
The plants are kept in a humidity saturated environment at 21°C for the incubation period of the fungus .
At the end of this period (7 days) , the fungicidal activity is evaluated according to a percentage evaluation scale from 0 (completely infected plant) to 100 (healthy plant) . All the compounds tested showed a fungus control of over 90 at a concentration of 1000 ppm. EXAMPLE 9.
Determination of the fungicidal activity against wheat powdery mildew (Erysiphe graminis) .
Leaves of wheat plants (cultivar Gemini) , cultivated in vases in a conditioned environment
(20±1°C, 70% relative humidity) are treated by spraying both sides of the leaves with compounds 1, 2 and 3, dispersed in a hydroacetone solution at 20% by volume of acetone.
After remaining 24 hours in a conditioned environment, the plants are sprayed on both sides of the leaves with an aqueous suspension of conidia of Erysiphe graminis (200000 conidia per cm3) .
The plants are kept in a humidity saturated environment at a temperature ranging from 18 to 24°C for the incubation period of the fungus.
At the end of this period (12 days) , the fungicidal activity is evaluated according to a percentage evaluation scale from 0 (completely infected plant) to 100 (healthy plant) .
All the compounds tested showed a fungus control of over 90 at a concentration of 1000 ppm. EXAMPLE 10. Determination of the fungicidal activity against wheat rust (Pυccinia recondi ta) .
Leaves of wheat plants (cultivar Gemini) , cultivated in vases in a conditioned environment (20±1°C, 70% relative humidity) are treated by spraying both sides of the leaves with compounds 1, 2 and 3, dispersed in a hydroacetone solution at 20% by volume of acetone.
After remaining 24 hours in a conditioned environment, the plants are sprayed on both sides of the leaves with an aqueous suspension of conidia of Puccinia recondita (200000 conidia per cm3) .
The plants are kept in a humidity saturated environment at a temperature ranging from 18 to 24°C for the incubation period of the fungus.
At the end of this period (14 days), the fungicidal activity is evaluated according to a percentage evaluation scale from 0 (completely infected plant) to 100 (healthy plant) . All the compounds tested showed a fungus control of over 90 at a concentration of 1000 ppm.

Claims

WHAT WE CLAIM IS Compounds having general formula (I)
(I) wherein:
Ri represents a hydrogen atom; a linear or branched Cι-C6 alkyl or haloalkyl group, optionally substituted; a C2-C6 alkenyl or haloalkenyl group, optionally substituted; a C2- C6 alkynyl or haloalkynyl group, optionally substituted; a C3-C6 cycloalkyl group, optionally substituted; an aryl group, optionally substituted; a heteroaryl group, optionally substituted; a heterocyclic group, optionally substituted; a halogen atom;
R2 represents a hydrogen atom; a halogen atom selected from chlorine, fluorine, bromine or iodine; a linear or branched Cι-C6 alkyl or haloalkyl group, optionally substituted; a linear or branched C2-C6 alkenyl or haloalkenyl group, optionally substituted; a linear or branched C2-C6 alkynyl or haloalkynyl group, optionally substituted; a C3-C6 cycloalkyl group, optionally substituted; a linear or branched Cι~ C6 alkoxy or haloalkoxy group, optionally substituted; a linear or branched Cι-C6 alkylthio or haloalkylthio group, optionally substituted; a C3-C6 cycloalkoxy group, optionally substituted; a cyano group; a linear or branched C2-C8 alkoxycarbonyl group, optionally substituted; an aminocarbonyl group; a linear or branched C2-C8 alkylaminocarbonyl group; a linear or branched C3-Cι5 dialkylaminocarbonyl group; a linear or branched C2-C8 alkylcarbonyl group, optionally substituted; an aryl group, optionally substituted or a heteroaryl group, optionally substituted; a heterocyclic group, optionally substituted; R3 and R4 independently represent a linear or branched Cι-C4 alkyl group;
R5, the same or different when n is greater than or equal to 2, represents a halogen atom, optionally selected from fluorine, chlorine, bromine or iodine; a linear or branched Cι-C6 haloalkyl group, optionally substituted; a linear or branched C-C6 alkoxy group, optionally substituted; a linear or branched Cι~C6 haloalkoxy group, optionally substituted; a linear or branched Cι-C6 alkylthio group, optionally substituted; a linear or branched CJ- C6 haloalkylthio group, optionally substituted; a C3-C6 cycloalkyl group optionally substituted; a linear or branched C2~C8 alkoxycarbonyl group; a cyano group; when Ri represents a linear or branched Cι-C6 haloalkyl group, substituted by at least two halogen atoms, the same or different, i.e. a linear or branched Cι-C6 polyhaloalkyl group, R5 also represents a linear or branched Ci-Ce alkyl group, optionally substituted; - Y represents an oxygen atom; an NH group;
Z represents a nitrogen atom or a CH group; n is a number ranging from 0 to 4.
2. The compounds according to claim 1, characterized in that they are an isomeric mixture in any proportion of the isomers E and Z of the compounds having formula (I) .
3. The compounds according to claim 1, characterized in that they are the isomer E or the isomer Z of the compounds having formula (I) .
4. The compounds according to claim 1, characterized in that they are the isomer E of the compounds having formula (I) .
5. The compounds according to claim 1 characterized in that the group Ri is selected from a linear or branched Cι-C6 alkyl or haloalkyl group, optionally substituted; a C3-C6 cycloalkyl group, optionally substituted; an aryl group, optionally substituted; a heteroaryl group, optionally substituted.
6. The compounds according to claim 1, characterized in that the group R2 is selected from a hydrogen atom; a halogen atom; a linear or branched Cι-C6 alkyl or haloalkyl group, optionally substituted; a C3-C6 cycloalkyl group, optionally substituted; a linear or branched C2-C8 alkoxycarbonyl group, optionally substituted.
7. The compounds according to claim 1, characterized in that R3 and R4 are equal to a methyl group.
8. The compounds according to claim 1, characterized in that R5 is selected from a halogen atom, a Cι-C6 haloalkyl group or, when Ri represents a Cι-C6 polyhaloalkyl group, R5 represents a linear or branched Cι-C6 alkyl group, optionally substituted.
9. The compounds according to claim 1, characterized in that n is equal to 0 or 1.
10. The compounds according to claim 1, characterized in that Z is equal to CH.
11. The compounds according to claim 1, characterized in that Y is an oxygen atom.
12. The compounds according to claim 1, characterized in that they are selected from:
(1) methyl (E) -3-methoxy-2-{2- [2- (trifluoromethyl) - 5-methyl-thiazol-4-yloxymethyl] phenyl} acrylate;
(2) methyl (E) -2-methoxyimino-2-{2- [2- (trifluoro- methyl) -5-methylthiazol-4-yloxymethyl] phenyl }- acetate;
(3) N-methyl- (E) -2-methoxyimino-2-{2- [2- (trifluoromethyl ) -5-methylthiazol-4-yloxymethyl ] phenyl } - acetamide; (4) methyl (E) -3-methoxy-2- {2- [2- (1, 1, 2, 2, 2-penta- fluoroethyl) -5-methylthiazol-4-yloxymethyl] - phenyl } acrylate;
(5) methyl (E) -3-methoxy-2-{2- [2- (1, 1, 2, 2-tetrafluoroethyl) -5-methylthiazol-4-yloxymethyl]- phenyl} acrylate;
(6) methyl (E) -3-methoxy-2- {2- [2- (1, 2, 2, 2-tetrafluoroethyl ) -5-methylthiazol-4-yloxymethyl ] - phenyl } acrylate; (7) methyl (E) -3-methoxy-2-{2- [2- (2, 2, 2-trifluoro- ethyl) -5-methylthiazol-4-yloxymethyl] henyl }- acrylate;
(8) methyl (E) -3-methoxy-2-{ 2- [2- (trifluoromethyl) - thiazol-4-yloxymethyl] henyl} acrylate;
(9) methyl (E) -3~methoxy-2- {2- [2- (trifluoromethyl) - 5-chlorothiazol-4-yloxymethyl] phenyl }acrylate;
(10) methyl (E) -3-methoxy-2- {2- [2- (trifluoromethyl) - 5-ethylthiazol-4-yloxymethyl] phenyl} acrylate; (11) methyl (E) -3-methoxy-2-{ 2- [2- (trifluoromethyl) - 5-cyclopropylthiazol-4-yloxymethyl] phenyl }- acrylate; (12) methyl (E) -3-methoxy-2-{2- [2- (difluoromethyl) -5- methylthiazol-4-yloxymethyl] phenyl} acrylate; (13) methyl (E) -3-methoxy-2-{ 2- [2- (chlorodifluoromethyl) -5-methylthiazol-4-yloxymethyl] phenyl}- acrylate; (14) methyl (E) -3-methoxy-2- [2- (2- (pyridin-2-yl) -5- methylthiazol-4-yloxymethyl) phenyl] acrylate; (15) methyl (E) -2-methoxyimino-2- [2- (2- (pyridin-2- yl) -5-methylthiazol-4-yloxymethyl) phenyl] - acetate; (16) N-methyl- (E) -2-methoxyimino-2- [2- (2- (pyridin-2- yl) -5-methylthiazol-4-yloxymethyl) phenyl] - acetamide; ( 17 ) methyl (E) -3-methoxy-2- [2- (2- (pyridin-3-yl ) -5- methylthiazol-4-yloxymethyl ) phenyl ] acrylate;
( 18 ) N-methyl- (E) -2-methoxyimino-2- [2- ( 2- (pyridin-3- yl ) -5-methyl thiazol-4-yloxymethyl) phenyl ] - acetamide;
(19) methyl (E) -3-methoxy-2- [2- (2- (pyridin-4-yl) -5- methylthiazol-4-yloxymethyl) phenyl] acrylate;
(20) N-methyl- (E) -2-methoxyimino-2- [2- (2- (pyridin-4- yl) -5-methyl-thiazol-4-yloxymethyl) phenyl] - acetamide;
(21) methyl (E) -3-methoxy-2- [2- (2- (4-chlorophenyl) -5- methyl-thiazol-4-yloxymethyl) phenyl] acrylate;
(22) N-methyl- (E) -2-methoxyimino-2- [2- (2- (2, 6- difluorophenyl) -thiazol-4-yloxymethyl) phenyl] - acetamide;
(23) methyl (E) -3-methoxy-2- [2- ( (2-cyclopropyl-5- methylthiazol-4-yloxymethyl) henyl] acrylate;
(24) methyl (E) -2-methoxyimino-2- [2- (2- (2-fluorophenyl) -5-methylthiazol-4-yloxymethyl) phenyl] - acetate;
(25) N-methyl- (E) -2-methoxyimino-2- [2- (2- (2-propyl) - 5-methylthiazol-4-yloxymethyl) phenyl] acetamide;
(26) methyl (E) -3-methoxy-2- [2- (2- (pyridin-2-yl) - thiazol-4-yloxymethyl) phenyl] acrylate; (27) methyl (E) -3-methoxy-2- [2- (2- (pyridin-2-yl) -5- trifluoromethylthiazol-4-yloxymethyl) phenyl] - acrylate;
(28) N-methyl- (E) -2-methoxyimino-2- [2- (2-phenyl-5- (methoxycarbonyl) thiazol-4-yloxymethyl) phenyl] - acetamide;
(29) N-methyl- (E) -2-methoxyimino-2- [2- (2- (4-methylphenyl) -5-cyanothiazol-4-yloxymethyl) phenyl] - acetamide; (30) methyl (E) -3-methoxy-2- [2- (2- (4-trifluoromethyl- phenyl) -5-cyclopropylthiazol-4-yloxymethyl) - phenyl] acrylate; (31) methyl (E) -3-methoxy-2- [2- (2- (2, 4-dichlorophenyl) -5-methoxylthiazol-4-yloxymethyl) phenyl] - acrylate.
13. A process for the preparation of the compounds having general formula (I) according to claims 1-12, characterized in that it comprises a condensation reaction of a compound having general formula (II) with a thiazolyl derivative having general formula (III), according to reaction scheme A: Scheme A
wherein Ri, R2, R3, R4, Rs, Yr Z and n have the meanings defined above, L represents an outgoing group such as a chlorine atom, a bromine atom, an RS03 ~ group wherein R represents a Cι-C6 alkyl or haloalkyl or a phenyl, optionally substituted.
14. The process according to claim 13, characterized in that the condensation is carried out in an inert organic solvent, at a temperature ranging from 0°C to the boiling point of the reaction mixture, optionally in the presence of an inorganic or organic base.
15. Use of the compounds having general formula (I) :
(I)
wherein:
Ri represents a hydrogen atom; a linear or branched Cι-C6 alkyl or haloalkyl group, optionally substituted; a C2-C3 alkenyl or haloalkenyl group, optionally substituted; a C2- C6 alkynyl or haloalkynyl group, optionally substituted; a C3-C6 cycloalkyl group, optionally substituted; an aryl group, optionally substituted; a heteroaryl group, optionally substituted; a heterocyclic group, optionally substituted; a halogen atom;
R2 represents a hydrogen atom; a halogen atom selected from chlorine, fluorine, bromine or iodine; a linear or branched Cι-C6 alkyl or haloalkyl group, optionally substituted; a linear or branched C2-C6 alkenyl or haloalkenyl group, optionally substituted; a linear or branched C2-C6 alkynyl or haloalkynyl group, optionally substituted; a C3-C6 cycloalkyl group, optionally substituted; a linear or branched Cχ~ C6 alkoxy or haloalkoxy group, optionally substituted; a linear or branched Cι~C6 alkylthio or haloalkylthio group, optionally substituted; a C3-C6 cycloalkoxy group, optionally substituted; a cyano group; a linear or branched C2-C8 alkoxycarbonyl group, optionally substituted; an a inocarbonyl group; a linear or branched C2-C8 alkylaminocarbonyl group; a linear or branched C3-C15 dialkylaminocarbonyl group; a linear or branched C2-C8 alkylcarbonyl group, optionally substituted; an aryl group, optionally substituted or a heteroaryl group, optionally substituted; a heterocyclic group, optionally substituted; R3 and R4 independently represent a linear or branched C1-C4 alkyl group;
R5, the same or different when n is greater than or equal to 2, represents a halogen atom, optionally selected from fluorine, chlorine, bromine or iodine; a linear or branched Cι-C6 haloalkyl group, optionally substituted; a linear or branched Cι-C6 alkoxy group, optionally substituted; a linear or branched Cι-C6 haloalkoxy group, optionally substituted; a linear or branched Cι-C6 alkylthio group, optionally substituted; a linear or branched Cx- C6 haloalkylthio group, optionally substituted; a C3-C6 cycloalkyl group optionally substituted; a linear or branched C2-C8 alkoxycarbonyl group; a cyano group; when Ri represents a linear or branched Cι-C6 haloalkyl group, substituted by at least two halogen atoms, the same or different, i.e. a linear or branched Cι-C6 polyhaloalkyl group, R5 also represents a linear or branched Cι-C6 alkyl group, optionally substituted; Y represents an oxygen atom; an NH group; Z represents a nitrogen atom or a CH group; n is a number ranging from 0 to 4. for the control of phytopathogenic fungi.
16. The use according to claim 15 of isomers E of the compounds having formula (I) .
17. Use of the compounds having general formula (I) according to any of the claims from 1 to 12, for the control of phytopathogenic fungi, in a curative and/or preventive application.
18. The use according to any of the claims 15-17 for the control of phytopathogenic fungi which attack vines, sugar beet crops, cereals, vegetables, rice crops, Cucurbitacaea, fruit trees.
19. The use of the compounds having general formula (I) according to any of the claims from 1 to 12, as insecticides and/or acaricides.
20. A method for controlling phytopathogenic fungi in agricultural crops by the application of the compounds having general formula (I) according to one of the claims 1-12.
21. The method according to claim 20, characterized in that the quantity of compound to be applied varies from 10 g to 5 kg per hectare.
22. The method according to claim 20, characterized in that the application is effected on all parts of the plant, for example on the leaves, stems, branches and roots, or on the seeds themselves before sowing, or on the ground in which the plant grows.
23. Fungicidal compositions containing as active principle one or more of the compounds having general formula (I) according to one of the claims 1-12.
24. The compositions according to claim 23, comprising other active principles compatible with the compounds having general formula (I), such as other fungicides, phytoregulators, antibiotics, herbicides, insecticides, fertilizers.
25. The compositions according to claim 24, characterized in that the other fungicides are selected from AC-382042, acibenzolar, ampropylphos, anilazine, azaconazole, azoxystrobin, benalaxyl (in its racemic form or as optically active R isomer) , benclothiaz, benomyl, bitertanol, blasticidin-S, bromuconazole, bupirimate, buthiobate, captafol, captan, carbendazim, carboxin, carpropamid, chinomethionat, chloroneb, chlorothalonil, chlozolinate, cyazofa id, cymoxanil, cyproconazole, cyprodinil, debacarb, dichlofluanid, dichlone, dichlobutrazol, dichlomezine, dichloran, dicyclomet, diethofencarb, diphenoconazole, diflumetorim, dimethirimol, dimethomorph, diniconazole, dinocap, a fungicide dipeptide, dipyrithione, ditalimphos, dithianon, dodemorph, dodine, edifenphos, epoxyconazole, ethaconazole, ethaboxam, ethirimol, ethoxyquin, etridiazole, famoxadone, fenamidone, fenaminosulf, fenapanil, fenarimol, fenbuconazole, fenfuram, fenhexamid, fenpiclonil, fenpropidin, fenpropimorph, fentin, ferbam, ferimzone, fluazinam, fludioxonil, flumetover, flumorph, fluoroimide, fluotrimazole, fluoxastrobin, fluquinconazole, flusilazole, flusulfamide, flutolanil, flutriafol, folpet, fosetylaluminium, fuberidazole, furalaxyl, furconazole, guazatine, hexaconazole, hydroxyquinoline sulfate, hymexazol, ICIA0858, imazalil, imibenconazole, iminoctadine, ipconazole, iprobenfos, iprodione, isoprothiolane, iprovalicarb, kasugamycin, kresoxim-methyl, mancopper, mancozeb, maneb, mebenil, mepanipyrim, mepronil, metalaxyl, metalaxyl-M, metconazole, methfuroxam, metiram, metsulfovax, MON-65500, myclobutanil, natamycin, nitrothal-isopropyl, nuarimol, ofurace, orisastrobin, oxadixyl, oxycarboxin, pefurazoate, penconazole, pencycuron, pentachlorophenol and its salts, phthalide, piperalin, Bordeaux mixture, polyoxins, probenazole, prochloraz, procymidone, propamocarb, propiconazole, propineb, proquinazid, prothiocarb, prothioconazole, pycoxystrobin, pyracarbolid, pyraclostrobin, pyrazophos, pyrifenox, pyrimethanil, pyroquilon, pyroxyfur, quinacetol, quinazamid, quinconazole, quinoxyfen, quintozene, rabenazole, copper hydroxide, copper oxychloride, copper sulfate, RH-7281, RPA-407213, simeconazolo, spiroxamine, spiromesifen, SSF-126 (metominostrobin) , streptomycin, SYP-L-190, tebuconazole, thiabendazole, thicyofen, thifluzamide, thiophanate-methyl, thiram, tioxymid, tolclofos-methyl, tolylfluanid, triadimefon, triadimenol, triarimol, triazbutil, triazoxide, tricyclazole, tridemorf, trifloxystrobin (CGA 279202) , triflumizole, triforine, triticonazole, validamycin, vinclozolin, zineb, ziram, sulfur, zoxamide .
26. The compositions according to one of the claims 23-25, characterized in that the concentration of the active principle ranges from 1% to 90%, preferably from 5 to 50%.
27. The use of the fungicidal compositions according to any of the claims 23-26 for the control of phytopathogenic fungi .
28. Compounds having general formula (III'):
(III') wherein Ri' represents a linear or branched polyhaloalkyl Ci- C6 group and
R2' represents a hydrogen atom; a halogen atom selected from chlorine, fluorine, bromine or iodine; a linear or branched Cι~C6 alkyl or haloalkyl group, optionally substituted; a linear or branched C2-C3 alkenyl or haloalkenyl group, optionally substituted; a linear or branched C2-C6 alkynyl or haloalkynyl group, optionally substituted; a C3-C6 cycloalkyl group, optionally substituted; a linear or branched Cι-C6 alkoxy or haloalkoxy group, optionally substituted; a linear or branched Cι-C6 alkylthio or haloalkylthio group, optionally substituted; a C3-C6 cycloalkoxy group, optionally substituted; a cyano group; a linear or branched C2-C8 alkoxycarbonyl group, optionally substituted; an aminocarbonyl group; a linear or branched C2-C8 alkylaminocarbonyl group; a linear or branched C3-C15 dialkyl- aminocarbonyl group; a linear or branched C-C8 alkylcarbonyl group, optionally substituted; an aryl group, optionally substituted or a heteroaryl group, optionally substituted; a heterocyclic group, optionally substituted.
29. The compounds according to claim 28, characterized in that Rx' is selected from difluoromethyl, chlorodifluoromethyl, trifluoromethyl, 2, 2, 2-trifluoroethyl, 2,2, 3, 3-tetrafluoropropyl, 2,2,3, 3, 3-pentafluoropropyl, 1,1,2,2,2- pentafluoroethyl; 1, 2, 2, 2-tetrafluoroethyl; 1,1,2,2- tetrafluoroethyl .
30. The compounds according to claim 28, characterized in that R2' is selected from a hydrogen atom; a halogen atom; a linear or branched Cι-C6 alkyl or haloalkyl group, optionally substituted; a C3-C6 cycloalkyl group, optionally substituted; an aryl group, optionally substituted; a heteroaryl group, optionally substituted; a cyano group; a linear or branched C2-C8 alkoxycarbonyl group, optionally substituted.
31. The compounds according to claim 28, characterized in that they are selected from:
(1) 2- (trifluoromethyl) -4-hydroxy-5-methylthiazole;
(2) 2- (trifluoromethyl) -4-hydroxy-5-chlorothiazole; (3) 2- (trifluoromethyl) -4-hydroxy-thiazole;
(4) 2- (trifluoromethyl) -4-hydroxy-5-cyclopropyl thiazole;
(5) 2- (trifluoromethyl) -4-hydroxy-5- (2- pyridyl) thiazole; (6) 2- (trifluoromethyl) -4-hydroxy-5- (2,4- dichlorophenyl) thiazole;
(7) 2- (trifluoromethyl) -4-hydroxy-5-cyanothiazole;
(8) 2- ( 1,1, 2,2, 2-pentafluoroethyl) -4-hydroxy-5- methylthiazole; (9) 2- (1, 1,2, 2, 2-pentafluoroethyl) -4-hydroxy-5- phenylthiazole;
(10) 2- (1, 1,2, 2, 2-pentafluoroethyl) -4- hydroxythiazole;
(11) 2- (2,2,2-trifluoroethyl)-4-hydroxy-5- methylthiazole;
(12) 2- (2, 2, 2-trifluoroethyl) -4-hydroxythiazole;
(13) 2- (1, 2, 2, 2-tetrafluoroethyl) -4-hydroxy-5- ethylthiazole;
(14) 2-(l,2,2, 2-tetrafluoroethyl ) -4-hydroxythiazole; (15) 2-(l,l,2, 2-tetrafluoroethyl) -4-hydroxy-5- methylthiazole;
(16) 2- (1,1, 2, 2-tetrafluoroethyl) -4-hydroxy-5- phenylthiazole; (17) 2- (1,1, 2, 2-tetrafluoroethyl) -4-hydroxythiazole;
(18) 2- (difluoromethyl-2- (difluoromethyl) -4-hydroxy- 5-methylthiazole;
(19) 2- (difluoromethyl) -4-hydroxythiazole;
(20) 2- (difluoromethyl) -4-hydroxy-5-cyclopentyl thiazole;
(21) 2- (chlorodifluoromethyl) -4-hydroxy-5- ethylthiazole;
(22) 2- (chlorodifluoromethyl) -4-hydroxy-thiazole;
(23) 2- (trifluoromethyl) -4-hydroxy-5-phenylthiazole; (24) 2- (trifluoromethyl) -4-hydroxy-5- ethoxycarbonylthiazole .
32. Use of the compounds having general formula
(III')
(III') according to any of the claims from 28 to 31, as intermediates for the preparation of compounds which can be used in both the pharmaceutical and agro- chemical field.
33. A process for the preparation of the compounds having general formula (III') according to any of the claims 28-31, characterized in that it comprises a condensation reaction between a thioamide having general formula (V) and a derivative having general formula (VI), according the reaction scheme B:
(V) (VI) (III')
Scheme B
wherein Ri' e R' have the meanings defined above, X represents a leaving group such as a chlorine atom, a bromine atom, an RS03 ~ group, W represents an OR group, wherein R has the meaning of a linear or branched Cι-C6 alkyl or haloalkyl or a phenyl, optionally substituted; or a halogen atom; or an NH2 group.
34. The process according to claim 33, characterized in that the reaction is carried out in an inert organic solvent, at a temperature ranging from -70°C to the boiling point of the reaction mixture, optionally in the presence of an inorganic or organic base.
35. A process for the preparation of the compounds having general formula (III') according to any of the claims 28-31, characterized in that it comprises a condensation between a nitrile having formula (VII) and a carboxylic derivative having formula (VIII) according to reaction scheme C:
(VII) (VIII) (III')
Scheme C wherein RX and R2' have the meanings defined above, T represents an OH group or an OR group wherein R has the meaning of a linear or branched CJ- C6 alkyl or haloalkyl, or a phenyl, optionally substituted.
36. The process according to claim 35, characterized in that the reaction is optionally carried out in the presence of an inert organic solvent, at a temperature ranging from -70°C to the boiling point of the reaction mixture, optionally in the presence of an inorganic or organic base or alternatively in the presence of an inorganic or organic acid.
EP02795153A 2001-12-13 2002-12-11 Thiazole derivatives with fungicidal activity Expired - Lifetime EP1453817B1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
ITMI20012640 ITMI20012640A1 (en) 2001-12-13 2001-12-13 NEW TAZOLIC DERIVATIVES WITH FUNGICIDE ACTIVITY
ITMI20010264 2001-12-13
IT2002MI000753A ITMI20020753A1 (en) 2002-04-09 2002-04-09 NEW FUNGICIDE AND INTERMEDIATE THIAZOLIC DERIVATIVES FOR THEIR PREPARATION
ITMI20020075 2002-04-09
PCT/EP2002/014070 WO2003050096A1 (en) 2001-12-13 2002-12-11 Thiazole derivatives with fungicidal activity

Publications (2)

Publication Number Publication Date
EP1453817A1 true EP1453817A1 (en) 2004-09-08
EP1453817B1 EP1453817B1 (en) 2006-04-26

Family

ID=26332793

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02795153A Expired - Lifetime EP1453817B1 (en) 2001-12-13 2002-12-11 Thiazole derivatives with fungicidal activity

Country Status (9)

Country Link
US (1) US7166620B2 (en)
EP (1) EP1453817B1 (en)
JP (1) JP2005511739A (en)
AT (1) ATE324370T1 (en)
AU (1) AU2002361049A1 (en)
BR (1) BR0214651A (en)
DE (1) DE60211018T2 (en)
ES (1) ES2263845T3 (en)
WO (1) WO2003050096A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070098900A1 (en) * 2004-11-05 2007-05-03 Fuji Hunt Photographic Chemicals, Inc. Media providing non-contacting formation of high contrast marks and method of using same, composition for forming a laser-markable coating, a laser-markable material and process of forming a marking
BR112016000386B1 (en) * 2013-07-12 2020-04-07 Sumitomo Chemical Co tetrazolinone compounds, their use, pyridine compounds, plague control agent and method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9122098D0 (en) 1991-10-17 1991-11-27 Ici Plc Fungicides
DE4305502A1 (en) * 1993-02-23 1994-08-25 Basf Ag Ortho-substituted 2-methoxyiminophenylacetic acid methylamides
WO1999040076A1 (en) * 1998-02-05 1999-08-12 Nippon Soda Co., Ltd. Thiazole compounds, production process, pest control agent, and antifungal agent

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO03050096A1 *

Also Published As

Publication number Publication date
DE60211018T2 (en) 2006-12-21
JP2005511739A (en) 2005-04-28
WO2003050096A1 (en) 2003-06-19
BR0214651A (en) 2004-09-14
DE60211018D1 (en) 2006-06-01
EP1453817B1 (en) 2006-04-26
ATE324370T1 (en) 2006-05-15
ES2263845T3 (en) 2006-12-16
AU2002361049A1 (en) 2003-06-23
US20050065197A1 (en) 2005-03-24
US7166620B2 (en) 2007-01-23

Similar Documents

Publication Publication Date Title
US10149473B2 (en) Aminoindanes amides having a high fungicidal activity and their phytosanitary compositions
AU2011347585A1 (en) Aminoindanes amides having a high fungicidal activity and their phytosanitary compositions
US7332518B2 (en) Carboxamides as fungicides in agriculture
WO2010109301A1 (en) Benzamidic compounds having fungicidal activity and relative use
ITMI20101564A1 (en) PHENYLAMIDINE WITH HIGH FUNGICIDAL ACTIVITY AND RELATED USE
US5668160A (en) Fungicidal oxazolyl and oxadiazolyl derivatives
WO2015121802A1 (en) Benzoylphenyl-formamidines having a fungicidal activity, their agronomic compositions and relative use
EP2231637B1 (en) Pyridazine fungicides
WO1998021174A1 (en) Strobilurine analogue compounds with fungicidal activity
EP1453817A1 (en) Thiazole derivatives with fungicidal activity
US6124356A (en) Fungicides
JP2007502314A (en) Copper salts of organic acids and their use as fungicides
ITMI20012640A1 (en) NEW TAZOLIC DERIVATIVES WITH FUNGICIDE ACTIVITY
WO1997038997A1 (en) Substituted oxazolidinediones and their use as fungicides
IT202000007234A1 (en) Compounds with fungicidal activity, relative agronomic compositions and use for the control of phytopathogenic fungi
ITMI20101575A1 (en) PHENYLAMIDINE WITH HIGH FUNGICIDAL ACTIVITY AND RELATED USE
WO1997038995A1 (en) Fungicidal oxazolidinedione derivatives
EP0909760A1 (en) New analogs of strobilurine having fungicidal properties, and their application for controlling phytopathogenous fungi

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040524

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO

17Q First examination report despatched

Effective date: 20041203

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: ISAGRO RICERCA S.R.L.

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SI SK TR

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060426

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060426

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060426

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060426

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060426

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060426

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060426

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REF Corresponds to:

Ref document number: 60211018

Country of ref document: DE

Date of ref document: 20060601

Kind code of ref document: P

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060726

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060726

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: AMMANN PATENTANWAELTE AG BERN

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060926

NLV1 Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20061211

ET Fr: translation filed
REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2263845

Country of ref document: ES

Kind code of ref document: T3

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20061231

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20070129

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060727

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060726

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060426

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060426

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20061211

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060426

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20091215

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20100113

Year of fee payment: 8

Ref country code: FR

Payment date: 20091221

Year of fee payment: 8

Ref country code: GB

Payment date: 20091209

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20091203

Year of fee payment: 8

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20091211

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20091222

Year of fee payment: 8

PGRI Patent reinstated in contracting state [announced from national office to epo]

Ref country code: IT

Effective date: 20110616

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20101211

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20110831

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20101231

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20110103

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20101231

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 60211018

Country of ref document: DE

Effective date: 20110701

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20110701

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20101211

PGRI Patent reinstated in contracting state [announced from national office to epo]

Ref country code: IT

Effective date: 20110616

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20120220

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20101212